drugId,yearApproval,brandDrugName,originalDrugName,drugName,targetIds,interactorIds,targetType,sponsor,properties,therapeuticArea,indication,diseaseName,diseaseIds,relatedIds,diseaseType,diseaseClass,reviewType,hasAnyGE,hasInteractorDiseasesGE,hasTargetRelatedGE,hasInteractorRelatedGE,hasTargetDiseaseGE
CHEMBL4297802,2018,Palynziq,Pegvaliase,PEGVALIASE,NA,NA,Original,BioMarin Pharmaceutical,PAL replacement therapy,No human target,Phenylketonuria,phenylketonuria,MONDO_0009861,NA,Original,Serious,"P,O,F",NA,NA,NA,NA,NA
"CHEMBL3039514,CHEMBL2063090",2016,Zepatier,"Elbasvir, grazoprevir","ELBASVIR,GRAZOPREVIR","NA,NA",NA,Original,Merck & Co.,NS5A inhibitor plus NS3/4A protease inhibitor,No human target,HCV genotypes 1 and 4,hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,B",NA,NA,NA,NA,NA
CHEMBL1650559,2018,Zemdri,Plazomicin,PLAZOMICIN,NA,NA,Original,Achaogen,Aminoglycoside antibacterial,No human target,Urinary tract infections,urinary tract infection,EFO_0003103,NA,Original,Not serious,P,NA,NA,NA,NA,NA
CHEMBL361497,2020,Artesunate,Artesunate,ARTESUNATE,NA,NA,Original,Amivas,Artemisinin antimalarial,No human target,Serious malaria,malaria,EFO_0001068,NA,Original,Serious,"P,O,B,F",NA,NA,NA,NA,NA
CHEMBL4297513,2021,Brexafemme,Ibrexafungerp,Ibrexafungerp,NA,NA,Original,Scynexis,Triterpenoid antifungal,No human target,Vulvovaginal candidiasis,NA,NA,NA,Original,NA,"P,F",NA,NA,NA,NA,NA
CHEMBL3989974,2019,Fetroja,Cefiderocol,CEFIDEROCOL,NA,NA,Original,Shionogi,Cephalosporin antibacterial,No human target,Complicated urinary tract infections,urinary tract infection,EFO_0003103,NA,Original,Not serious,"P,F",NA,NA,NA,NA,NA
"CHEMBL3127326,CHEMBL3391662,CHEMBL3137312,CHEMBL163",2014,Viekira Pak,"Ombitasvir, paritaprevir, dasabuvir, ritonavir","OMBITASVIR,PARITAPREVIR,DASABUVIR,RITONAVIR","NA,NA,NA,ENSG00000021461,ENSG00000160870,ENSG00000106258,ENSG00000160868",NA,Original,AbbVie,An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor,Other indication,Chronic HCV genotype 1 infection,hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,B,F",NA,FALSE,FALSE,FALSE,NA
CHEMBL2219415,2013,Dotarem,Gadoterate meglumine,GADOTERATEMEGLUMINE,NA,NA,Original,Guerbet,Gadolinium-based contrast agent,No human target,Contrast agent to visualize disruption of the blood-brain barrier,NA,NA,NA,Original,NA,P,NA,NA,NA,NA,NA
CHEMBL110,2017,Benznidazole,Benznidazole,BENZNIDAZOLE,NA,NA,Original,Chemo Research,Nitroimidazole antimicrobial,No human target,Chagas disease,Chagas disease,MONDO_0001444,NA,Original,Serious,"P,O,A",NA,NA,NA,NA,NA
CHEMBL1257073,2018,TPOXX,Tecovirimat,TECOVIRIMAT,NA,NA,Original,SIGA Technologies,Viral p37 protein inhibitor,No human target,Smallpox,smallpox,MONDO_0004651,NA,Original,Serious,"P,O,F",NA,NA,NA,NA,NA
CHEMBL125,2014,Impavido,Miltefosine,MILTEFOSINE,NA,NA,Original,Knight,MOA unknown,No human target,Leishmaniasis,Leishmaniasis,EFO_0005044,NA,Original,Not concordant,"P,O,F",NA,NA,NA,NA,NA
CHEMBL1257051,2014,Sivextro,Tedizolid,TEDIZOLID,NA,NA,Original,Cubist,Oxazolidinone-class antibacterial,No human target,ABSSSI (Acute Bacterial Skin and Skin Structure Infections),staphylococcal skin infections,EFO_1001849,NA,Original,Not serious,P,NA,NA,NA,NA,NA
CHEMBL2108670,2016,Zinplava,Bezlotoxumab,BEZLOTOXUMAB,NA,NA,Original,Merck & Co.,mAb against Clostridium difficile toxin,No human target,C. difficile recurrence,clostridium difficile infection,EFO_0009130,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
CHEMBL4298110,2019,Accrufer,Ferric maltol,FERRICMALTOL,NA,NA,Original,Shield Therapeutics,Iron replacement product,No human target,Iron deficiency anaemia,iron deficiency anemia,HP_0001891,EFO_0004272,Original,Not serious,S,NA,NA,NA,NA,NA
CHEMBL1688530,2014,Orbactiv,Oritavancin,ORITAVANCIN,NA,NA,Original,The Medicines Company,Semi-synthetic lipoglycopeptide,No human target,ABSSSI (Acute Bacterial Skin and Skin Structure Infections),staphylococcal skin infections,EFO_1001849,NA,Original,Not serious,P,NA,NA,NA,NA,NA
CHEMBL1908370,2014,Xtoro,Finafloxacin,FINAFLOXACIN,NA,NA,Original,Alcon,Fluoroquinolone antimicrobial,No human target,Acute otitis externa (swimmer's ear),otitis externa,EFO_0009560,NA,Original,Not serious,P,NA,NA,NA,NA,NA
CHEMBL4594411,2022,Xenoview,Xenon Xe 129 hyperpolarized,XenonXe129hyperpolarized,NA,NA,Original,Polarean,Hyperpolarized contrast agent,No human target,MRI-evaluation of lung ventilation,NA,NA,NA,Original,NA,S,NA,NA,NA,NA,NA
CHEMBL205596,2015,Cholbam,Cholic acid,CHOLICACID,NA,NA,Original,Retrophin,A primary bile acid,No human target,Bile acid synthesis disorders and peroxisomal disorders,peroxisomal disease; Disorder of bile acid synthesis,"MONDO_0019053,Orphanet_79168",NA,Original,Serious,"P,O",NA,NA,NA,NA,NA
CHEMBL290960,2020,Lampit,Nifurtimox,NIFURTIMOX,NA,NA,Original,Bayer,Nitrofuran antiprotozoal,No human target,Chagas disease,chagas disease,MONDO_0001444,NA,Original,Serious,"P,O,A",NA,NA,NA,NA,NA
CHEMBL1951095,2018,Xerava,Eravacycline,ERAVACYCLINE,NA,NA,Original,Tetraphase Pharmaceuticals,Tetracycline antibiotic,No human target,Complicated intra-abdominal infections,infectious disease,EFO_0005741,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
"CHEMBL3545363,CHEMBL3545123",2017,Mavyret,"Glecaprevir, pibrentasvir","GLECAPREVIR,PIBRENTASVIR","NA,NA",NA,Original,AbbVie,NS3/4A protease inhibitor plus a NS5A inhibitor,No human target,HCV,hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,B,F",NA,NA,NA,NA,NA
CHEMBL406393,2015,Kybella,Deoxycholic acid,DEOXYCHOLICACID,NA,NA,Original,Kythera,Cytolytic drug,No human target,Fat below the chin,body fat distribution,EFO_0004341,NA,Original,Not serious,S,NA,NA,NA,NA,NA
"CHEMBL127,CHEMBL3317857",2017,Vabomere,"Meropenem, vaborbactam","MEROPENEM,VABORBACTAM","NA,NA",NA,Original,The Medicines Company/Rempex Pharmaceuticals,Carbapenem antimicrobial plus a ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-lactamase inhibitor,No human target,Complicated urinary tract infections,urinary tract infection,EFO_0003103,NA,Original,Not serious,"P,F",NA,NA,NA,NA,NA
CHEMBL498847,2017,Solosec,Secnidazole,SECNIDAZOLE,NA,NA,Original,Lupin,Nitroimidazole antimicrobial,No human target,Bacterial vaginosis,bacterial vaginosis,EFO_0003932,NA,Original,Not serious,"P,F",NA,NA,NA,NA,NA
CHEMBL1661,2020,Pizensy,Lactitol,LACTITOL,NA,NA,Original,Braintree Labs,Osmotic laxative,No human target,Chronic idiopathic constipation,Chronic constipation,HP_0012450,NA,Original,Not serious,S,NA,NA,NA,NA,NA
CHEMBL437765,2018,Aemcolo,Rifamycin,RIFAMYCIN,NA,NA,Original,Cosmo Technologies,Ansamycin antibacterial,No human target,Travellers diarrhoea,Diarrhea,HP_0002014,NA,Original,Not serious,"P,F",NA,NA,NA,NA,NA
CHEMBL501849,2013,Olysio,Simeprevir,SIMEPREVIR,NA,NA,Original,Janssen,HCV NS3/4A protease inhibitor,No human target,"Chronic HCV infection, as a component of a combination antiviral treatment regimen",hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
"CHEMBL1259059,CHEMBL3545062,CHEMBL3707372",2017,Vosevi,"Sofosbuvir, velpatasvir, voxilaprevir","SOFOSBUVIR,VELPATASVIR,VOXILAPREVIR","NA,NA,NA",NA,Original,Gilead Sciences,Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor,No human target,HCV,hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,B",NA,NA,NA,NA,NA
"CHEMBL3989866,CHEMBL885,CHEMBL2107825",2018,Biktarvy,"Bictegravir, emtricitabine, tenofovir alafenamide","BICTEGRAVIR,EMTRICITABINE,TENOFOVIRALAFENAMIDE","NA,NA,NA",NA,Original,Gilead Sciences,HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors,No human target,HIV,hiv infection,EFO_0000764,NA,Original,Serious,P,NA,NA,NA,NA,NA
CHEMBL2104415,2018,Moxidectin,Moxidectin,MOXIDECTIN,NA,NA,Original,Medicines Development for Global Health,Antihelmintic GABA receptor and glutamate channel modulator,No human target,River blindness,ocular onchocerciasis,EFO_0007398,NA,Original,Not concordant,"P,O",NA,NA,NA,NA,NA
CHEMBL298470,2018,Krintafel,Tafenoquine,TAFENOQUINE,NA,NA,Original,Medicines for Malaria Venture/GlaxoSmithKline,8-Aminoquinoline antimalarial,No human target,Plasmodium vivax malaria,Plasmodium vivax malaria,EFO_0007445,NA,Original,Serious,"P,O,B,F",NA,NA,NA,NA,NA
CHEMBL2364608,2018,Pifeltro,Doravirine,DORAVIRINE,NA,NA,Original,Merck & Co.,NNRTI,No human target,HIV,hiv infection,EFO_0000764,NA,Original,Serious,S,NA,NA,NA,NA,NA
"CHEMBL1689063,CHEMBL44354",2015,Avycaz,"Avibactam, ceftazidime","AVIBACTAM,CEFTAZIDIME","NA,NA",NA,Original,Allergan,A beta-lactamase inhibitor and a cephalosporin,No human target,Complicated intra-abdominal infections and complicated urinary tract infections,infection,EFO_0000544,Orphanet_169142,Original,Serious,"P,F",NA,NA,NA,NA,NA
CHEMBL3301594,2020,Rukobia,Fostemsavir,FOSTEMSAVIR,NA,NA,Original,ViiV Healthcare,Attachment inhibitor,No human target,HIV,hiv infection,EFO_0000764,NA,Original,Serious,"P,B,F",NA,NA,NA,NA,NA
CHEMBL443052,2014,Kerydin,Tavaborole,TAVABOROLE,NA,NA,Original,Anacor,Oxaborole antifungal,No human target,Onychomycosis of the toenails,paronychia,EFO_0007421,NA,Original,Not serious,S,NA,NA,NA,NA,NA
"CHEMBL204656,CHEMBL2095208,CHEMBL885,CHEMBL483",2015,Genvoya,"Elvitegravir, cobicistat, emtricitabine, tenofovir","ELVITEGRAVIR,COBICISTAT,EMTRICITABINE,TENOFOVIR","NA,ENSG00000160870,ENSG00000106258,ENSG00000160868,ENSG00000021461,NA,NA",NA,Original,Gilead,An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors,No human target,HIV,HIV infection,EFO_0000764,NA,Original,Serious,"S,F",NA,FALSE,FALSE,FALSE,NA
CHEMBL4297634,2022,Elucirem,Gadopiclenol,Gadopiclenol,NA,NA,Original,Guerbet,Gadolinium-based contrast agent,No human target,Lesions with abnormal vascularity,NA,NA,NA,Original,NA,P,NA,NA,NA,NA,NA
"CHEMBL2103872,CHEMBL404",2014,Zerbaxa,"Ceftolozane, tazobactam","CEFTOLOZANE,TAZOBACTAM","NA,NA",NA,Original,Cubist,A cephalosporin antibacterial plus a beta-lactamase inhibitor,No human target,Complicated intra-abdominal infections and complicated urinary tract infections,infection,EFO_0000544,Orphanet_169142,Original,Serious,"P,F",NA,NA,NA,NA,NA
CHEMBL1689772,2018,Nuzyra,Omadacycline,OMADACYCLINE,NA,NA,Original,Paratek Pharmaceuticals,Tetracycline antibiotic,No human target,CABP and ABSSSI,bacterial pneumonia; skin disease caused by bacterial infection,"EFO_1001272,MONDO_0024295",NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
CHEMBL290916,2017,Radicava,Edaravone,EDARAVONE,NA,NA,Original,Mitsubishi Tanabe,Unknown (radical scavenger),No human target,ALS (amyotrophic lateral sclerosis),amyotrophic lateral sclerosis,MONDO_0004976,NA,Original,Serious,"S,O",NA,NA,NA,NA,NA
CHEMBL4297620,2019,Sunosi,Solriamfetol,SOLRIAMFETOL,NA,NA,Original,Jazz,Dopamine and noradrenaline reuptake inhibitor,No human target,Excessive sleepiness due to narcolepsy or obstructive sleep apnoea,hypersomnia; narcolepsy; obstructive sleep apnea,"EFO_0005246,MONDO_0021107,EFO_0003918",NA,Original,Serious,"S,O",NA,NA,NA,NA,NA
CHEMBL4594438,2022,Sunlenca,Lenacapavir,Lenacapavir,NA,NA,Original,Gilead,HIV-1 capsid inhibitor,No human target,HIV-1 infection,HIV-1 infection,EFO_0000180,NA,Original,NA,"P,B,F",NA,NA,NA,NA,NA
"CHEMBL2403238,CHEMBL175691",2021,Cabenuva Kit,"Cabotegravir, rilpivirine","Cabotegravir,rilpivirine","NA,NA",NA,Original,ViiV,INSTI and an NNRTI,No human target,HIV-1 infection,NA,NA,NA,Original,NA,"P,F",NA,NA,NA,NA,NA
CHEMBL3544996,2015,Praxbind,Idarucizumab,IDARUCIZUMAB,NA,NA,Original,Boehringer Ingelheim,Dabigatran-binding mAb fragment,No human target,Reversal of anticoagulant effects of dabigatran,response to anticoagulant,GO_0061476,NA,Original,Not serious,"P,O,B,A",NA,NA,NA,NA,NA
"CHEMBL766,CHEMBL148,CHEMBL3301605",2019,Recarbrio,"Cilastatin, imipenem, relebactam","CILASTATIN,IMIPENEM,RELEBACTAM","ENSG00000015413,NA,NA",NA,Original,Merck & Co.,"A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor",No human target,Complicated urinary tract and complicated intra-abdominal infections,urinary tract infection,EFO_0003103,NA,Original,Not serious,"P,F",NA,FALSE,FALSE,FALSE,NA
CHEMBL4594388,2020,Ebanga,Ansuvimab,ANSUVIMAB,NA,NA,Original,Ridgeback,Ebola glycoprotein-directed mAb,No human target,Ebola virus,Ebola hemorrhagic fever,EFO_0007243,NA,Original,Serious,"P,O,B",NA,NA,NA,NA,NA
CHEMBL1086440,2019,Egaten,Triclabendazole,TRICLABENDAZOLE,NA,NA,Original,Novartis,Anthelmintic,No human target,Fascioliasis,fascioliasis,EFO_1001324,NA,Original,Not concordant,"P,O,F",NA,NA,NA,NA,NA
CHEMBL2205807,2020,Xeglyze,Abametapir,ABAMETAPIR,NA,NA,Original,Dr Reddy‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¥‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®‚Äö√Ñ¬¢s,Metalloproteinase inhibitor,No human target,Head lice,lice infestation,MONDO_0003472,NA,Original,Not serious,S,NA,NA,NA,NA,NA
CHEMBL4065616,2020,Veklury,Remdesivir,REMDESIVIR,NA,NA,Original,Gilead,Nucleotide analogue RNA polymerase inhibitor,No human target,COVID-19,covid-19,MONDO_0100096,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
CHEMBL4297503,2018,Xofluza,Baloxavir marboxil,BALOXAVIRMARBOXIL,NA,NA,Original,Shionogi/Roche,Polymerase acidic endonuclease inhibitor,No human target,Acute uncomplicated influenza,influenza,EFO_0007328,NA,Original,Not serious,P,NA,NA,NA,NA,NA
CHEMBL3291398,2019,Xenleta,Lefamulin,LEFAMULIN,NA,NA,Original,Nabriva,Pleuromutilin antibacterial,No human target,CABP,bacterial pneumonia,EFO_1001272,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
"CHEMBL3989402,CHEMBL139367",2014,Rapivab,Peramivir,"PERAMIVIR,PERAMIVIR","NA,NA",NA,Original,BioCryst,Neuraminidase inhibitor,No human target,Influenza infection,influenza,EFO_0007328,NA,Original,Not serious,"S,F",NA,NA,NA,NA,NA
CHEMBL100259,2015,Xuriden,Uridine,URIDINE,NA,NA,Original,Wellstat,Pyrimidine analogue,No human target,Hereditary orotic aciduria,Hereditary orotic aciduria,Orphanet_30,NA,Original,Serious,"P,O,B",NA,NA,NA,NA,NA
CHEMBL515408,2021,Livtencity,Maribavir,Maribavir,NA,NA,Original,Takeda,CMV pUL97 kinase inhibitor,No human target,Post-transplant CMV infection,NA,NA,NA,Original,NA,"P,O,B",NA,NA,NA,NA,NA
CHEMBL2107816,2013,Xofigo,Radium RA 223 dichloride,RADIUMRA223DICHLORIDE,NA,NA,Original,Bayer,Alpha particle-emitting radioactive therapeutic,No human target,Castration-resistant prostate cancer,prostate cancer,MONDO_0008315,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
CHEMBL1259059,2013,Sovaldi,Sofosbuvir,SOFOSBUVIR,NA,NA,Original,Gilead,HCV nucleotide analogue NS5B polymerase inhibitor,No human target,"Chronic HCV infection, as a component of a combination antiviral treatment regimen",hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,B,F",NA,NA,NA,NA,NA
CHEMBL2364632,2018,Seysara,Sarecycline,SARECYCLINE,NA,NA,Original,Allergan,Tetracycline antibiotic,No human target,Serious acne vulgaris,acne,EFO_0003894,NA,Original,Not serious,S,NA,NA,NA,NA,NA
CHEMBL2111107,2015,Bridion,Sugammadex,SUGAMMADEX,NA,NA,Original,Merck & Co.,A modified gamma cyclodextrin,No human target,Reversal of neuromuscular blockade during surgery,neuromuscular disease,EFO_1001902,NA,Original,Serious,P,NA,NA,NA,NA,NA
CHEMBL3400972,2019,Fluorodopa F-18,Fluorodopa F-18,FLUORODOPAF-18,NA,NA,Original,Feinstein Institutes,Radioactive diagnostic,No human target,Diagnosis of parkinsonian syndromes,Parkinson disease,MONDO_0005180,NA,Original,Serious,S,NA,NA,NA,NA,NA
CHEMBL3301592,2018,Lokelma,Sodium zirconium cyclosilicate,SODIUMZIRCONIUMCYCLOSILICATE,NA,NA,Original,AstraZeneca,Potassium binder,No human target,Hyperkalaemia,hyperkalemia,HP_0002153,NA,Original,Not concordant,S,NA,NA,NA,NA,NA
CHEMBL2105637,2017,Baxdela,Delafloxacin,DELAFLOXACIN,NA,NA,Original,Melinta Therapeutics,Fluoroquinolone antibacterial,No human target,Acute bacterial skin and skin structure infections,staphylococcal skin infections,EFO_1001849,NA,Original,Not serious,"P,F",NA,NA,NA,NA,NA
CHEMBL450449,2015,Yondelis,Trabectedin,TRABECTEDIN,NA,NA,Original,Johnson & Johnson,Alkylating drug,NA,Liposarcoma or leiomyosarcoma,liposarcoma; leiomyosarcoma,"EFO_0000569,EFO_0000564",NA,Original,Serious,"P,O",NA,NA,NA,NA,NA
CHEMBL3301669,2014,Dalvance,Dalbavancin,DALBAVANCIN,NA,NA,Original,Durata,Semisynthetic lipoglycopeptide,No human target,ABSSSI (Acute Bacterial Skin and Skin Structure Infections),staphylococcal skin infections,EFO_1001849,NA,Original,Not serious,"P,F",NA,NA,NA,NA,NA
"CHEMBL4298183,CHEMBL4298188,CHEMBL4298184",2020,Inmazeb,"Atoltivimab, odesivimab, maftivimab","ATOLTIVIMAB,ODESIVIMAB,MAFTIVIMAB","NA,NA,NA",NA,Original,Regeneron,Cocktail of Ebola glycoprotein-directed mAbs,No human target,Ebola virus,Ebola hemorrhagic fever,EFO_0007243,NA,Original,Serious,"P,O,B",NA,NA,NA,NA,NA
CHEMBL2107840,2015,Veltassa,Patiromer sorbitex,PATIROMERSORBITEX,NA,NA,Original,Relypsa,Potassium binder,No human target,Hyperkalaemia,Hyperkalemia,HP_0002153,NA,Original,Not concordant,S,NA,NA,NA,NA,NA
CHEMBL3311228,2022,Vivjoa,Oteseconazole,Oteseconazole,NA,NA,Original,Mycovia,Azole antifungal,No human target,Vulvovaginal candidiasis,vulvovaginal candidiasis,EFO_0007543,NA,Original,NA,"P,F",NA,NA,NA,NA,NA
CHEMBL4594264,2019,ExEm Foam,Air polymer-type A,AIRPOLYMER-TYPEA,NA,NA,Original,Giskit,Ultrasound contrast agent,No human target,Assess fallopian tube patency in women with known or suspected infertility,infertility,EFO_0000545,NA,Original,Not serious,S,NA,NA,NA,NA,NA
CHEMBL4297535,2018,Omegaven,Fish oil triglycerides,FISHOILTRIGLYCERIDES,NA,NA,Original,Fresenius,Mixture of fatty acids,No human target,Parenteral nutrition-associated cholestasis,cholestasis,MONDO_0001751,NA,Original,Serious,"P,O,F",NA,NA,NA,NA,NA
CHEMBL3990047,2017,Xepi,Ozenoxacin,OZENOXACIN,NA,NA,Original,Ferrer Internacional,Quinolone antimicrobial,No human target,Impetigo due to Staphylococcus aureus or Streptococcus pyogenes,impetigo,EFO_1000714,NA,Original,Not serious,S,NA,NA,NA,NA,NA
CHEMBL1229211,2013,Tivicay,Dolutegravir,DOLUTEGRAVIR,NA,NA,Original,ViiV,HIV1 integrase strand transfer inhibitor,No human target,"HIV1 infection in adults and children, in combination with other antiretroviral agents",HIV infection,EFO_0000764,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
NA,2022,NexoBrid,Anacaulase,Anacaulase,NA,NA,Original,Mediwound,Proteolytic enzymes from pineapple plants,No human target,Eschar removal after thermal burns,NA,NA,NA,Original,NA,"S,O",NA,NA,NA,NA,NA
"CHEMBL1746,CHEMBL272427",2022,Relyvrio,"Sodium phenylbutyrate, taurursodiol","Sodiumphenylbutyrate,taurursodiol","NA,NA",NA,Original,Amylyx,Mechanism unknown,No human target,Amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,MONDO_0004976,NA,Original,Serious,"P,O",NA,NA,NA,NA,NA
CHEMBL2023898,2015,Daklinza,Daclatasvir,DACLATASVIR,NA,NA,Original,Bristol-Myers Squibb,NS5A inhibitor,No human target,HCV,hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,F",NA,NA,NA,NA,NA
CHEMBL3544926,2016,Anthim,Obiltoxaximab,OBILTOXAXIMAB,NA,NA,Original,Elusys Therapeutics,mAb against anthrax toxin,No human target,Anthrax,anthrax infection,EFO_0000778,NA,Original,Serious,"S,O,F",NA,NA,NA,NA,NA
CHEMBL227875,2019,Pretomanid,Pretomanid,PRETOMANID,NA,NA,Original,Pfizer/Mylan,Antimycobacterial,No human target,Tuberculosis,tuberculosis,MONDO_0018076,NA,Original,Serious,"P,O,F",NA,NA,NA,NA,NA
CHEMBL4303060,2021,Pepaxto,Melphalan flufenamide,Melphalanflufenamide,NA,NA,Original,Oncopeptides,Peptide-conjugated alkylating drug,NA,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Original,Serious,"P,O,A",NA,NA,NA,NA,NA
CHEMBL4297585,2020,Dojolvi,Triheptanoin,TRIHEPTANOIN,NA,NA,Original,Ultragenyx,Medium-chain triglyceride,No human target,LC-FAODs,inherited fatty acid metabolism disorder,MONDO_0037858,NA,Original,Serious,"S,O,F",NA,NA,NA,NA,NA
"CHEMBL2079130,CHEMBL1082,CHEMBL1741",2022,Voquezna Triple Pak,"Vonoprazan, amoxicillin, clarithromycin","Vonoprazan,amoxicillin,clarithromycin","ENSG00000186009,ENSG00000105675,NA,NA",NA,Original,Phathom,Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial,Other indication,Helicobacter pylori infection,Helicobacter pylori infectious disease,EFO_1000961,NA,Original,Not serious,"P,F",NA,FALSE,FALSE,FALSE,NA
CHEMBL1863514,2021,Rylaze,Asparaginase erwinia chrysanthemi,Asparaginaseerwiniachrysanthemi,NA,NA,Original,Jazz,Recombinant asparagine-specific enzyme,NA,"ALL and LBL, in patients allergic to E. coli-derived products",acute lymphoblastic leukemia; lymphoblastic lymphoma,"EFO_0000220,MONDO_0000873",NA,Original,Serious,"S,O,F",NA,NA,NA,NA,NA
CHEMBL1256391,2014,Esbriet,Pirfenidone,PIRFENIDONE,NA,NA,Original,InterMune,MOA unknown,No human target,IPF (idiopathic pulmonary fibrosis),idiopathic pulmonary fibrosis,EFO_0000768,NA,Original,Serious,"P,O,B,F",NA,NA,NA,NA,NA
CHEMBL2103877,2014,Jublia,Efinaconazole,EFINACONAZOLE,NA,NA,Original,Dow,Azole antifungal,No human target,Onychomycosis of the toenails,paronychia,EFO_0007421,NA,Original,Not serious,S,NA,NA,NA,NA,NA
"CHEMBL2374220,CHEMBL1259059",2014,Harvoni,"Ledipasvir, sofosbuvir","LEDIPASVIR,SOFOSBUVIR","NA,NA",NA,Original,Gilead Sciences,An NS5A inhibitor plus an HCV nucleotide-analogue NS5B-polymerase inhibitor,No human target,Genotype 1 HCV,hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,B,F",NA,NA,NA,NA,NA
CHEMBL1631694,2021,Fexinidazole,Fexinidazole,Fexinidazole,NA,NA,Original,Sanofi/DNDi,Nitroimidazole antimicrobial,No human target,Sleeping sickness,NA,NA,NA,Original,NA,"P,O",NA,NA,NA,NA,NA
CHEMBL2105689,2013,Luzu,Luliconazole,LULICONAZOLE,NA,NA,Original,Medicis,Azole antifungal,No human target,"Interdigital tinea pedis, tinea cruris and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum",tinea,EFO_0007510,NA,Original,Not serious,S,NA,NA,NA,NA,NA
CHEMBL4297984,2020,Danyelza,Naxitamab,NAXITAMAB,NA,NA,Original,Y-mAbs Therapeutics,GD2-directed mAb,NA,High-risk neuroblastoma,neuroblastoma,EFO_0000621,NA,Original,Serious,"P,O,B,A",NA,NA,NA,NA,NA
CHEMBL3137342,2015,Unituxin,Dinutuximab,DINUTUXIMAB,NA,NA,Original,United Therapeutics,GD2-binding mAb,NA,Neuroblastoma,neuroblastoma,EFO_0000621,NA,Original,Serious,"P,O",NA,NA,NA,NA,NA
CHEMBL4297516,2020,Zepzelca,Lurbinectedin,LURBINECTEDIN,NA,NA,Original,Jazz,Alkylating drug,NA,Small-cell lung cancer,small cell lung carcinoma,EFO_0000702,NA,Original,Serious,"P,O,A",NA,NA,NA,NA,NA
"CHEMBL1259059,CHEMBL3545062",2016,Epclusa,"Sofosbuvir, velpatasvir","SOFOSBUVIR,VELPATASVIR","NA,NA",NA,Original,Gilead Sciences,A nucleotide analogue NS5B polymerase inhibitor plus an HCV NS5A inhibitor,No human target,"genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV)",hepatitis C virus infection,EFO_0003047,NA,Original,Serious,"P,B,F",NA,NA,NA,NA,NA
CHEMBL1183349,2015,Cresemba,Isavuconazonium,ISAVUCONAZONIUM,NA,NA,Original,Astellas,Azole antifungal,No human target,Antifungal,aspergillosis; mucormycosis,"EFO_0007157,EFO_0007380",NA,Original,Serious,"P,O",NA,NA,NA,NA,NA
CHEMBL4173394,2019,Tissueblue,Brilliant Blue G,BRILLIANTBLUEG,NA,NA,Original,Dutch Ophthalmic Research,Brilliant Blue G dye,No human target,Staining the internal limiting membrane,NA,NA,NA,Original,NA,"P,O",NA,NA,NA,NA,NA
NA,2014,Lumason,Sulfur hexafluoride lipid-type A microspheres,SULFURHEXAFLUORIDELIPID-TYPEAMICROSPHERES,NA,NA,Original,Bracco,Ultrasound contrast agent,No human target,Cardiovascular imaging,NA,NA,NA,Original,NA,S,NA,NA,NA,NA,NA
CHEMBL1241951,2017,Prevymis,Letermovir,LETERMOVIR,NA,NA,Original,Merck & Co.,CMV DNA terminase complex inhibitor,No human target,Prophylaxis of CMV (cytomegalovirus),cytomegalovirus infection,EFO_0001062,NA,Original,Serious,"P,O,B,F",NA,NA,NA,NA,NA
CHEMBL17860,2018,Lucemyra,Lofexidine,LOFEXIDINE,"ENSG00000150594,ENSG00000274286,ENSG00000184160",NA,Original,US WorldMeds,beta2-adrenoceptor agonist,Other indication,Opioid withdrawal,opioid dependence,EFO_0005611,NA,Original,Not serious,"P,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL1201891,2017,Emflaza,Deflazacort,DEFLAZACORT,ENSG00000113580,NA,Original,PTC Therapeutics,Corticosteroid,Other indication,Duchenne muscular dystrophy,Duchenne muscular dystrophy,MONDO_0010679,NA,Original,Serious,"P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE
"CHEMBL206253,CHEMBL1189679",2014,Akynzeo,"Netupitant, palonosetron","NETUPITANT,PALONOSETRON","ENSG00000115353,ENSG00000166736",NA,Original,Helsinn,An NK1-receptor antagonist plus a 5-HT3-receptor antagonist,Other indication,Chemotherapy-related nausea,Chemotherapy-induced nausea and vomiting,EFO_0006911,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3304485,2019,Ibsrela,Tenapanor,TENAPANOR,ENSG00000066230,NA,Original,Ardelyx,NHE3 inhibitor,Other indication,IBS with constipation,irritable bowel syndrome,EFO_0000555,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2107826,2020,Gemtesa,Vibegron,VIBEGRON,ENSG00000188778,NA,Original,Urovant Sciences,Beta-3 adrenergic receptor agonist,Other indication,Overactive bladder,overactive bladder,EFO_1000781,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2159122,2015,Viberzi,Eluxadoline,ELUXADOLINE,ENSG00000112038,NA,Original,Allergan,Mu-opioid receptor agonist,Other indication,Irritable bowel syndrome,irritable bowel syndrome,EFO_0000555,NA,Original,Not serious,"P,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297551,2021,Vyvgart,Efgartigimod alfa,Efgartigimodalfa,ENSG00000104870,NA,Original,Argenx,FcRn-binding Fc fragment,Other indication,Myasthenia gravis,Myasthenia gravis,EFO_0004991,NA,Original,Serious,"S,O,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2108041,2017,Ocrevus,Ocrelizumab,OCRELIZUMAB,ENSG00000156738,NA,Original,Roche/Genentech,CD20-directed cytolytic antibody,Other indication,Relapsing or primary progressive forms of multiple sclerosis,chronic progressive multiple sclerosis,EFO_0003840,NA,Original,Serious,"P,B,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2048028,2016,Xiidra,Lifitegrast,LIFITEGRAST,"ENSG00000160255,ENSG00000005844",NA,Original,Shire Pharmaceuticals,LFA1 antagonist,Other indication,Dry eye disease,dry eye syndrome,EFO_1000906,NA,Original,Not serious,P,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297229,2019,Jeuveau,Prabotulinumtoxin A,PRABOTULINUMTOXINA,ENSG00000132639,NA,Original,Evolus,Acetylcholine release inhibitor and a neuromuscular blocking agent,Other indication,Glabellar lines associated with corrugator and/or procerus muscle activity,Facial wrinkling,HP_0009762,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3707313,2019,Aklief,Trifarotene,TRIFAROTENE,ENSG00000172819,NA,Original,Galderma,Retinoic acid receptor agonist,Other indication,Acne vulgaris,acne,EFO_0003894,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2219418,2014,Movantik,Naloxegol,NALOXEGOL,ENSG00000112038,NA,Original,AstraZeneca,Opioid-receptor antagonist,Other indication,Opioid-induced constipation,Constipation,HP_0002019,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4594250,2017,Rhopressa,Netarsudil,NETARSUDIL,"ENSG00000134318,ENSG00000067900",NA,Original,Aerie Pharmaceuticals,RHO kinase inhibitor,Other indication,Open-angle glaucoma or ocular hypertension,open-angle glaucoma; ocular hypertension,"EFO_0004190,EFO_1001069",NA,Original,Serious,P,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL243712,2020,Barhemsys,Amisulpride,AMISULPRIDE,"ENSG00000151577,ENSG00000149295,ENSG00000164270,ENSG00000157219,ENSG00000158748,ENSG00000166736,ENSG00000186090,ENSG00000178084,ENSG00000102468,ENSG00000149305,ENSG00000179097,ENSG00000135914,ENSG00000178394,ENSG00000168830,ENSG00000147246,ENSG00000186038,ENSG00000148680,ENSG00000135312,ENSG00000179546",NA,Original,Acacia,Dopamine receptors D2 & D3 antagonist,Other indication,Nausea and vomiting after surgery,Nausea and vomiting,HP_0002017,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3348963,2017,Xermelo,Telotristat etiprate,TELOTRISTATETIPRATE,"ENSG00000129167,ENSG00000139287",NA,Original,Lexicon Pharmaceuticals,Tryptophan hydroxylase inhibitor,Other indication,Carcinoid syndrome diarrhoea,carcinoid syndrome; Diarrhea,"EFO_1000852,HP_0002014",NA,Original,Not serious,"P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297760,2019,Givlaari,Givosiran,GIVOSIRAN,ENSG00000023330,NA,Original,Alnylam,ALAS1-directed siRNA,Other indication,Acute hepatic porphyria,acute hepatic porphyria,Orphanet_95157,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL1743079,2020,Tepezza,Teprotumumab,TEPROTUMUMAB,ENSG00000140443,NA,Original,Horizon Therapeutics,IGF1R-directed mAb,Other indication,Thyroid eye disease,Graves disease,EFO_0004237,NA,Original,Not concordant,"P,O,B,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2364612,2017,Vyzulta,Latanoprostene bunod,LATANOPROSTENEBUNOD,ENSG00000122420,NA,Original,Bausch and Lomb/Valeant Pharmaceuticals,Prostaglandin analogue,Other indication,Intraocular pressure,intraocular pressure measurement,EFO_0004695,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2108728,2018,Asparlas,Calaspargase pegol,CALASPARGASEPEGOL,ENSG00000166183,NA,Original,Servier,Asparagine specific enzyme,Oncology,ALL,acute lymphoblastic leukemia,EFO_0000220,NA,Original,Serious,"S,O",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL354077,2018,Firdapse,Amifampridine,AMIFAMPRIDINE,"ENSG00000130037,ENSG00000182255,ENSG00000173826,ENSG00000111262,ENSG00000178342,ENSG00000131398,ENSG00000140015,ENSG00000055118,ENSG00000168418,ENSG00000143473,ENSG00000183960,ENSG00000151079,ENSG00000184408,ENSG00000116396,ENSG00000171126,ENSG00000168263,ENSG00000026559,ENSG00000170745,ENSG00000185760,ENSG00000135519,ENSG00000184156,ENSG00000075043,ENSG00000117013,ENSG00000158445,ENSG00000166006,ENSG00000129159,ENSG00000124134,ENSG00000156486,ENSG00000143105,ENSG00000182674,ENSG00000053918,ENSG00000089558,ENSG00000177301,ENSG00000162975,ENSG00000102057,ENSG00000184611,ENSG00000171385,ENSG00000177272,ENSG00000104848,ENSG00000164794",NA,Original,Catalyst Pharmaceuticals,Potassium channel blocker,Other indication,Lambert-Eaton myasthenic syndrome,Lambert-Eaton myasthenic syndrome,Orphanet_43393,NA,Original,Serious,"P,O",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL1742991,2017,Fasenra,Benralizumab,BENRALIZUMAB,ENSG00000091181,NA,Original,AstraZeneca,IL-5Ralpha-directed monoclonal antibody,Other indication,Serious asthma,Status Asthmaticus,EFO_0008590,"MONDO_0004979,MONDO_0004979",Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2103867,2017,Trulance,Plecanatide,PLECANATIDE,ENSG00000070019,NA,Original,Synergy Pharmaceuticals,Guanylate cyclase C agonist,Other indication,Chronic idiopathic constipation,Chronic constipation,HP_0012450,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2108738,2014,Opdivo,Nivolumab,NIVOLUMAB,ENSG00000188389,NA,Original,Bristol-Myers Squibb,PD1 inhibitor,Oncology,Unresectable or metastatic melanoma,metastatic melanoma,EFO_0002617,EFO_0000756,Original,Serious,"P,O,B,A,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297911,2022,Spevigo,Spesolimab,Spesolimab,"ENSG00000115598,ENSG00000196083",NA,Original,Boehringer Ingelheim,IL-36R-targeted mAb,Other indication,Generalized pustular psoriasis flares,"psoriasis 14, pustular",MONDO_0013626,NA,Original,Not concordant,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL1743068,2015,Cosentyx,Secukinumab,SECUKINUMAB,ENSG00000112115,NA,Original,Novartis,IL-17A antagonist,Other indication,"Plaque psoriasis, *psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.",psoriasis vulgaris,EFO_1001494,EFO_0000676,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297334,2021,Pylarify,Piflufolastat F-18,PiflufolastatF-18,ENSG00000086205,NA,Original,Progenics,Radiolabelled PSMA imaging agent,Other indication,Prostate cancer imaging,prostate carcinoma,EFO_0001663,NA,Original,Serious,P,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2005186,2021,Rezurock,Belumosudil,Belumosudil,"ENSG00000134318,ENSG00000067900",NA,Original,Kadmon,ROCK2 kinase inhibitor,Other indication,Chronic GVHD,graft versus host disease,MONDO_0013730,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2108726,2013,Lymphoseek kit,Technetium TC 99m tilmanocept,TECHNETIUMTC99MTILMANOCEPT,ENSG00000260314,NA,Original,Navidea,Radioactive diagnostic agent,Other indication,Lymphatic mapping in patients with breast cancer or melanoma,breast cancer; melanoma,"MONDO_0007254,EFO_0000756",NA,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4594271,2020,Orladeyo,Berotralstatc,BEROTRALSTAT,ENSG00000164344,NA,Original,BioCryst,Plasma kallikrein inhibitor,#N/A,Hereditary angioedema,hereditary angioedema,MONDO_0019623,NA,Original,Serious,"S,O,F",FALSE,NA,NA,NA,FALSE
CHEMBL334966,2015,Kengreal,Cangrelor,CANGRELOR,ENSG00000169313,NA,Original,Medicines Company,P2Y12 platelet inhibitor,Other indication,"Myocardial infarction, repeat coronary revascularization, and stent thrombosis",myocardial infarction,EFO_0000612,NA,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2443262,2020,Olinvyk,Oliceridine,OLICERIDINE,ENSG00000112038,NA,Original,Trevena,Opioid receptor agonist,Other indication,Acute pain,pain,EFO_0003843,NA,Original,Not serious,"S,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2108354,2022,Briumvi,Ublituximab,Ublituximab,ENSG00000156738,NA,Original,TG Therapeutics,CD20-targeted mAb,Other indication,Relapsing forms of multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,MONDO_0005301,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3707359,2022,Daxxify,DaxibotulinumtoxinA,DaxibotulinumtoxinA,ENSG00000132639,NA,Original,Revance,Botulinum toxin,Other indication,Glabellar lines,Facial wrinkling,HP_0009762,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2108677,2014,Plegridy,Peginterferon beta-1A,PEGINTERFERONBETA-1A,"ENSG00000159110,ENSG00000142166",NA,Original,Biogen Idec,Long-acting interferon-beta1A,Other indication,Relapsing multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,MONDO_0005301,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3989871,2021,Tavneos,Avacopan,Avacopan,ENSG00000197405,NA,Original,ChemoCentryx,Complement 5a receptor antagonist,Other indication,ANCA-associated vasculitis,Anti-neutrophil cytoplasmic antibody-associated vasculitis,MONDO_0015492,NA,Original,Serious,"S,O",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2336071,2019,Mayzent,Siponimod,SIPONIMOD,ENSG00000170989,NA,Original,Novartis,S1P receptor modulator,Other indication,Relapsing forms of multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,MONDO_0005301,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL117287,2018,Motegrity,Prucalopride,PRUCALOPRIDE,ENSG00000164270,NA,Original,Shire/Takeda,5-HT4-receptor agonist,Other indication,Chronic idiopathic constipation,constipation disorder,MONDO_0002203,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3137343,2014,Keytruda,Pembrolizumab,PEMBROLIZUMAB,ENSG00000188389,NA,Original,Merck & Co.,PD1-specific antibody,Oncology,Metastatic melanoma *and others (2021 approval),metastatic melanoma,EFO_0002617,EFO_0000756,Original,Serious,"P,O,B,A",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297990,2022,Kimmtrak,Tebentafusp,Tebentafusp,ENSG00000185664,NA,Original,Immunocore,gp100 peptide HLA _ CD3 bispecific T-cell engager,Oncology,Uveal melanoma,Uveal Melanoma,EFO_1000616,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL1743034,2016,Taltz,Ixekizumab,IXEKIZUMAB,ENSG00000112115,NA,Original,Eli Lilly,IL-17A antagonist,Other indication,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,EFO_0000676,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297832,2022,Enjaymo,Sutimlimab,Sutimlimab,ENSG00000182326,NA,Original,Bioverativ,C1s-targeted mAb,Other indication,RBC transfusion due to haemolysis in CAD (cold agglutinin disease),"Anemia, Hemolytic, Autoimmune",EFO_1001264,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3707331,2015,Varubi,Rolapitant,ROLAPITANT,ENSG00000115353,NA,Original,Tesaro,Neurokinin 1 receptor antagonist,Other indication,Nausea and vomiting associated with chemotherapy,Chemotherapy-induced nausea and vomiting,EFO_0006911,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297734,2019,Adakveo,Crizanlizumab,CRIZANLIZUMAB,ENSG00000174175,NA,Original,Novartis,P-selectin blocker,Other indication,Painful complications of SCD,sickle cell disease and related diseases,MONDO_0017146,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3545189,2018,Takhzyro,Lanadelumab,LANADELUMAB,ENSG00000164344,NA,Original,Dyax/Shire,Kallikrein antibody,Other indication,Hereditary angioedema,hereditary angioedema,MONDO_0019623,NA,Original,Serious,"P,O,B,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL462605,2019,Wakix,Pitolisant,PITOLISANT,ENSG00000101180,NA,Original,Harmony,H3-receptor antagonist/inverse agonist,Other indication,Excessive sleepiness due to narcolepsy,narcolepsy,MONDO_0021107,NA,Original,Serious,"P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL298734,2020,Zokinvy,Lonafarnib,LONAFARNIB,"ENSG00000257365,ENSG00000168522",NA,Original,Eiger,Farnesyltransferase inhibitor,Other indication,HGPS,hutchinson-gilford progeria syndrome,MONDO_0008310,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL231068,2015,Addyi,Flibanserin,FLIBANSERIN,"ENSG00000178394,ENSG00000102468,ENSG00000069696",NA,Original,Sprout,Serotonin receptor modulator,Other indication,Hypoactive sexual desire disorder,sexual dysfunction,EFO_0004714,"EFO_0008343,EFO_0008343",Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2135460,2022,Terlivaz,Terlipressin,Terlipressin,ENSG00000166148,NA,Original,Mallinckrodt,Vasopressin receptor agonist,Other indication,Kidney function in hepatorenal syndrome,Hepatorenal syndrome,MONDO_0001382,HP_0006554,Original,Serious,"P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2109334,2020,Uplizna,Inebilizumab,INEBILIZUMAB,ENSG00000177455,NA,Original,Viela Bio,CD19-directed mAb,Other indication,NMOSD,neuromyelitis optica,EFO_0004256,MONDO_0000568,Original,Serious,"S,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL493982,2014,Zontivity,Vorapaxar,VORAPAXAR,ENSG00000181104,NA,Original,Merck & Co.,Protease-activated receptor 1 antagonist,Other indication,Thrombotic cardiovascular events (after myocardial infarction or with peripheral arterial disease*),myocardial infarction; peripheral arterial disease,"EFO_0000612,EFO_0004265",NA,Original,Serious,"S,F",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297412,2021,Cytalux,Pafolacianine,Pafolacianine,ENSG00000110195,NA,Original,On Target Labs,Fluorescent FR imaging agent,Other indication,Ovarian cancer imaging,ovarian carcinoma,EFO_0001075,NA,Original,Serious,"P,O,F",FALSE,FALSE,FALSE,FALSE,FALSE
"CHEMBL1189679,CHEMBL3989917",2018,Akynzeo IV,"Palonosetron, fosnetupitant","PALONOSETRON,FOSNETUPITANT","ENSG00000166736,ENSG00000115353",NA,Original,Helsinn Group,5-HT3-receptor antagonist and NK1-receptor antagonist,Other indication,Chemotherapy-induced emesis,Chemotherapy-induced nausea and vomiting,EFO_0006911,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3039520,2019,Reyvow,Lasmiditan,LASMIDITAN,ENSG00000179097,NA,Original,Eli Lilly,Serotonin (5-HT) 1F receptor agonist,Other indication,Migraine with or without aura,migraine disorder,MONDO_0005277,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3545313,2020,Nexletol,Bempedoic acid,BEMPEDOICACID,ENSG00000131473,NA,Original,Esperion Therapeutics,ACL inhibitor,Other indication,HeFH or atherosclerotic cardiovascular disease,atherosclerosis; familial hypercholesterolemia,"EFO_0003914,EFO_0004911",NA,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297741,2021,Zegalogue,Dasiglucagon,Dasiglucagon,ENSG00000215644,NA,Original,Zealand Pharma,Glucagon receptor agonist,Other indication,Serious hypoglycaemia,GCGR-related hyperglucagonemia,EFO_0001360,NA,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2105755,2017,Symproic,Naldemedine,NALDEMEDINE,ENSG00000112038,NA,Original,Shionogi,Opioid antagonist,Other indication,Opioid-induced constipation,Constipation,HP_0002019,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL238804,2015,Uptravi,Selexipag,SELEXIPAG,ENSG00000160013,NA,Original,Actelion,Prostacyclin receptor agonist,Other indication,Pulmonary arterial hypertension,pulmonary arterial hypertension,EFO_0001361,EFO_0000537,Original,Serious,"S,O",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL306700,2021,Qelbree,Viloxazine,Viloxazine,ENSG00000103546,NA,Original,Supernus,SNRI,Other indication,ADHD,attention deficit hyperactivity disorder,EFO_0003888,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297573,2018,Elzonris,Tagraxofusp,TAGRAXOFUSP,"ENSG00000167658,ENSG00000185291",NA,Original,Stemline Therapeutics,IL-3 and diphtheria toxin fusion protein,Oncology,Blastic plasmacytoid dendritic cell neoplasm,blastic plasmacytoid dendritic cell neoplasm,EFO_0010580,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL3989915,2021,Korsuva,Difelikefalin,Difelikefalin,ENSG00000082556,NA,Original,Cara Therapeutics,kappa-Opioid receptor agonist,Other indication,Pruritus associated with CKD,chronic kidney disease,EFO_0003884,HP_0012594,Original,Serious,"P,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297666,2022,Omlonti,Omidenepag isopropyl,Omidenepagisopropyl,ENSG00000125384,NA,Original,Santen,Prostaglandin E2 receptor agonist,Other indication,Intraocular pressure in open-angle glaucoma or ocular hypertension,"ocular hypertension, open-angle glaucoma","EFO_1001069,EFO_0004190",NA,Original,Serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2110588,2014,Cerdelga,Eliglustat,ELIGLUSTAT,ENSG00000148154,NA,Original,Genzyme,Glucosylceramide-synthase inhibitor,Other indication,Gaucher's disease,Gaucher disease,MONDO_0018150,NA,Original,Serious,"P,O",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL4297779,2020,Oxlumo,Lumasiran,LUMASIRAN,ENSG00000101323,NA,Original,Alnylam,HAO1-directed siRNA,Other indication,Hyperoxaluria type 1,primary hyperoxaluria type 1,MONDO_0009823,NA,Original,Serious,"P,O,B",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2146883,2015,Cotellic,Cobimetinib,COBIMETINIB,"ENSG00000126934,ENSG00000169032","ENSG00000132155,ENSG00000157764,ENSG00000078061,ENSG00000100030,ENSG00000108953,ENSG00000102882,ENSG00000109971,ENSG00000137693,ENSG00000141068,ENSG00000142192,ENSG00000166913,ENSG00000172530",Original,Genentech,MEK inhibitor,Oncology,Melanoma with BRAFV600E/K mutations,melanoma,EFO_0000756,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1096146,2021,Ponvory,Ponesimod,Ponesimod,ENSG00000170989,ENSG00000110848,Interactor,J&J,S1P receptor modulator,Other indication,Relapsing multiple sclerosis,multiple sclerosis,MONDO_0005301,NA,Original,Serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL1983268,2019,Rozlytrek,Entrectinib,ENTRECTINIB,"ENSG00000148053,ENSG00000198400,ENSG00000140538,ENSG00000047936,ENSG00000171094","ENSG00000105976,ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000198400,ENSG00000081237,ENSG00000096384,ENSG00000111679,ENSG00000124181,ENSG00000127329,ENSG00000135333,ENSG00000140538,ENSG00000145675,ENSG00000162733,ENSG00000206503,ENSG00000160691,ENSG00000006125,ENSG00000071537,ENSG00000127947,ENSG00000134259,ENSG00000142192,ENSG00000149177",Original,Roche,"TRKA, TRKB, TRKC, ROS1 and ALK inhibitor",Oncology,NTRK fusion-positive solid tumours and ROS1-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297774,2021,Rybrevant,Amivantamab,Amivantamab,"ENSG00000105976,ENSG00000146648","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000010671,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000140538,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000152894,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000185338,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000007264,ENSG00000010017,ENSG00000011485,ENSG00000019991,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000070159,ENSG00000071051,ENSG00000071537,ENSG00000074966,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115290,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000134215,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000141738,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000160293,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000198753,ENSG00000213658,ENSG00000253729",Original,J&J,EGFRxMETR bispecific antibody,Oncology,EGFR exon 20-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1743047,2015,Portrazza,Necitumumab,NECITUMUMAB,ENSG00000146648,"ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729",Original,Eli Lilly,EGFR antagonist,Oncology,NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"S,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3183409,2018,Erleada,Apalutamide,APALUTAMIDE,ENSG00000169083,"ENSG00000169083,ENSG00000005339,ENSG00000010671,ENSG00000084676,ENSG00000089280,ENSG00000097007,ENSG00000101213,ENSG00000106462,ENSG00000109685,ENSG00000110092,ENSG00000118058,ENSG00000124181,ENSG00000129514,ENSG00000136504,ENSG00000136826,ENSG00000140396,ENSG00000141027,ENSG00000141867,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000157554,ENSG00000159388,ENSG00000165025,ENSG00000167548,ENSG00000168036,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000184634,ENSG00000197122,ENSG00000204209,ENSG00000254087,ENSG00000125686,ENSG00000142515,ENSG00000145715,ENSG00000160691,ENSG00000266412",Original,Johnson & Johnson,Androgen receptor inhibitor,Oncology,Prostate cancer,prostate cancer,MONDO_0008315,NA,Original,Serious,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707290,2020,Sogroya,Somapacitan,SOMAPACITAN,ENSG00000112964,"ENSG00000112964,ENSG00000196396",Original,Novo Nordisk,Growth hormone analogue,Other indication,Growth hormone deficiency,short stature due to partial GHR deficiency,MONDO_0011420,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3833320,2020,Vyepti,Eptinezumab,EPTINEZUMAB,"ENSG00000110680,ENSG00000175868","ENSG00000157087,ENSG00000110680",Original,Lundbeck,CGRP-directed mAb,Other indication,Migraine,migraine disorder,MONDO_0005277,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297839,2022,Mounjaro,Tirzepatide,Tirzepatide,"ENSG00000010310,ENSG00000112164","NA,ENSG00000159224",Original,Eli Lilly,GIP receptor and GLP1 receptor agonist,Other indication,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545184,2017,Parsabiv,Etelcalcetide,VELCALCETIDE,ENSG00000036828,ENSG00000036828,Original,Amgen/Kai Pharmaceuticals,Calcium-sensing receptor agonist,Other indication,Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis,hyperparathyroidism,EFO_0008506,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297522,2020,Pemazyre,Pemigatinib,PEMIGATINIB,"ENSG00000066468,ENSG00000068078,ENSG00000077782","ENSG00000066468,ENSG00000065361,ENSG00000145675",Original,Incyte,FGFR1-3 kinase inhibitor,Oncology,Cholangiocarcinoma,cholangiocarcinoma,EFO_0005221,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3402762,2021,Tepmetko,Tepotinib,Tepotinib,ENSG00000105976,"ENSG00000105976,ENSG00000146648,ENSG00000010671,ENSG00000081237,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000140538,ENSG00000143322,ENSG00000145675,ENSG00000152894,ENSG00000165025,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000185338,ENSG00000197122,ENSG00000254087,ENSG00000160691,ENSG00000177885,ENSG00000101336,ENSG00000136205,ENSG00000000938,ENSG00000007264,ENSG00000010017,ENSG00000019991,ENSG00000070159,ENSG00000071051,ENSG00000074966,ENSG00000105647,ENSG00000115290,ENSG00000117461,ENSG00000127947,ENSG00000131746,ENSG00000134215,ENSG00000141738,ENSG00000145715,ENSG00000149177,ENSG00000158092,ENSG00000160293,ENSG00000176105,ENSG00000197943,ENSG00000198753",Original,EMD Serono,MET kinase inhibitor,Oncology,NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545311,2017,Alunbrig,Brigatinib,BRIGATINIB,"ENSG00000171094,ENSG00000146648","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000171094,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729",Original,Ariad Pharmaceuticals/Takeda,ALK inhibitor,Oncology,ALK-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL3237547,CHEMBL1201129",2020,Inqovi,"Cedazuridine, decitabine","CEDAZURIDINE,DECITABINE","ENSG00000158825,ENSG00000119772,ENSG00000130816","ENSG00000106462,ENSG00000119772,ENSG00000163041,ENSG00000109101,ENSG00000198945",Original,Otsuka,Cytidine deaminase inhibitor; nucleoside metabolic inhibitor,Other indication,Myelodysplastic syndromes,myelodysplastic syndrome,EFO_0000198,NA,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707357,2019,Beovu,Brolucizumab,BROLUCIZUMAB,ENSG00000112715,"ENSG00000099250,ENSG00000112715",Original,Novartis,VEGF inhibitor,Other indication,Wet age-related macular degeneration,macular degeneration,EFO_0009606,NA,Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1089318,2020,Ongentys,Opicapone,OPICAPONE,ENSG00000093010,"ENSG00000103266,ENSG00000109501,ENSG00000099377",Original,Neurocrine,COMT inhibitor,Other indication,Parkinson disease,parkinson disease,MONDO_0005180,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2105720,2015,Zurampic,Lesinurad,LESINURAD,ENSG00000197891,NA,Original,AstraZeneca,URAT1 inhibitor,Other indication,Gout,gout,EFO_0004274,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4298124,2021,Jemperli,Dostarlimab,Dostarlimab,ENSG00000188389,"ENSG00000120217,ENSG00000179295,ENSG00000197646,ENSG00000006125",Original,GlaxoSmithKline,PD1-targeted mAb,Oncology,Endometrial cancer,endometrial cancer,MONDO_0011962,NA,Original,Serious,"P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1269025,2015,Savaysa,Edoxaban,EDOXABAN,ENSG00000126218,"ENSG00000117601,NA",Original,Daiichi Sankyo,Factor Xa inhibitor,Other indication,"Risk of stroke and systemic embolism in NVAF, and deep vein thrombosis",atrial fibrillation; deep vein thrombosis,"EFO_0000275,EFO_0003907",NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1743029,2018,Trogarzo,Ibalizumab,IBALIZUMAB,ENSG00000010610,ENSG00000160791,Interactor,TaiMed Biologics/Theratechnologies,CD4 antibody,Other indication,HIV,hiv infection,EFO_0000764,NA,Original,Serious,"P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2364639,2017,Ingrezza,Valbenazine,VALBENAZINE,ENSG00000165646,"ENSG00000173250,ENSG00000139514,ENSG00000180871,NA",Original,Neurocrine Biosciences,VMAT2 inhibitor,Other indication,Tardive dyskinesia,movement disorder,EFO_0004280,NA,Original,Not concordant,"P,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3989868,2020,Tukysa,Tucatinib,TUCATINIB,ENSG00000141736,"ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122",Original,Seagen,HER2 kinase inhibitor,Oncology,HER2-positive breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108675,2017,Dupixent,Dupilumab,DUPILUMAB,ENSG00000077238,"ENSG00000077238,ENSG00000111679,ENSG00000113520,ENSG00000131724,ENSG00000166888",Original,Regeneron/Sanofi,IL-4Ralpha antagonist,Other indication,Atopic dermatitis,atopic eczema,EFO_0000274,"HP_0000964,MONDO_0002406",Original,Not serious,"P,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545262,2020,Trodelvy,Sacituzumab govitecan,SACITUZUMABGOVITECAN,"ENSG00000198900,ENSG00000184292","ENSG00000091831,ENSG00000097007,ENSG00000122566,ENSG00000136997,ENSG00000147140,ENSG00000181163",Original,Immunomedics/Gilead,"TROP2-directed ADC, with topoisomerase inhibitor",Oncology,Triple-negative breast cancer (and advanced or metastatic urothelial cancer (mUC)*),triple-negative breast cancer; urothelial carcinoma,"EFO_0005537,EFO_0008528",NA,Original,Serious,"P,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3813873,2019,Turalio,Pexidartinib,PEXIDARTINIB,"ENSG00000182578,ENSG00000122025,ENSG00000157404",NA,Original,Daiichi Sankyo,"CSF1R, KIT and FLT3 inhibitor",Oncology,Tenosynovial giant cell tumour,Tenosynovial Giant Cell Tumor,EFO_1000562,MONDO_0002171,Related,Serious,"P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3301610,2017,Verzenio,Abemaciclib,ABEMACICLIB,"ENSG00000105810,ENSG00000135446","ENSG00000110092,ENSG00000179750",Interactor,Eli Lilly,CDK4/6 inhibitor,Oncology,"HR-positive, HER2-negative breast cancer",HER2 negative breast carcinoma,EFO_0009780,EFO_0000305,Related,Serious,"P,B,F",TRUE,TRUE,TRUE,FALSE,FALSE
CHEMBL3353410,2015,Tagrisso,Osimertinib,OSIMERTINIB,ENSG00000146648,"ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729",Original,AstraZeneca,EGFR inhibitor,Oncology,NSCLC with EGFRT790M mutations,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4585668,2021,Welireg,Belzutifan,Belzutifan,ENSG00000116016,ENSG00000134086,Interactor,Merck & Co.,HIF-2alpha inhibitor,Oncology,von Hippel-Lindau disease,von Hippel-Lindau disease,MONDO_0008667,EFO_0000681,Related,Serious,"P,O",TRUE,TRUE,TRUE,FALSE,FALSE
"CHEMBL426084,CHEMBL715",2021,Lybalvi,"Olanzapine, samidorphan","samidorphan,Olanzapine","ENSG00000112038,ENSG00000116329,ENSG00000082556,ENSG00000102468,ENSG00000147246,ENSG00000151577,ENSG00000069696,ENSG00000149295","ENSG00000162975,ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142192,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000180720,ENSG00000103042,ENSG00000132965,ENSG00000174437,ENSG00000205279,ENSG00000134640,ENSG00000149295,NA",Original,Alkermes,Atypical antipsychotic and opioid antagonist,Other indication,Schizophrenia and bipolar I disorder,Schizophrenia; bipolar I disorder,"MONDO_0005090,EFO_0009963",NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL190461,2018,Epidiolex,Cannabidiol,CANNABIDIOL,ENSG00000118432,NA,Original,GW Pharmaceuticals,Cannabinoid,Other indication,Dravet syndrome and Lennox-Gastaut syndrome,Dravet syndrome; Lennox-Gastaut syndrome,"Orphanet_33069,MONDO_0016532",MONDO_0020072,Related,Serious,"P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL4101807,2019,Oxbryta,Voxelotor,VOXELOTOR,"ENSG00000206172,ENSG00000244734,ENSG00000188536","ENSG00000244734,ENSG00000130656,ENSG00000169877,ENSG00000176155,ENSG00000188536,ENSG00000206172,ENSG00000196565,ENSG00000213931",Original,Global Blood Therapeutics,Haemoglobin S polymerization inhibitor,Other indication,SCD (sickle cell disease),sickle cell anemia,MONDO_0011382,NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2105719,2018,Vizimpro,Dacomitinib,DACOMITINIB,"ENSG00000178568,ENSG00000146648,ENSG00000141736","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000152894,ENSG00000153201,ENSG00000153707,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185338,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000075624,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000007264,ENSG00000010810,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000070159,ENSG00000071051,ENSG00000071537,ENSG00000074966,ENSG00000078747,ENSG00000087586,ENSG00000088930,ENSG00000090776,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000132535,ENSG00000134215,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138095,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000141738,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000160293,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000173406,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729",Original,Pfizer,EGFR inhibitor,Oncology,EGFR-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2035187,2022,Vonjo,Pacritinib,Pacritinib,"ENSG00000096968,ENSG00000122025","ENSG00000096968,ENSG00000097007,ENSG00000117400,ENSG00000122025,ENSG00000179295",Original,CTI Biopharma,JAK2 inhibitor,Oncology,Myelofibrosis,myelofibrosis,MONDO_0044903,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3894860,2021,Cosela,Trilaciclib,Trilaciclib,"ENSG00000135446,ENSG00000105810","ENSG00000096384,ENSG00000106462,ENSG00000110092,ENSG00000111087,ENSG00000111276,ENSG00000112576,ENSG00000118689,ENSG00000118971,ENSG00000119866,ENSG00000123080,ENSG00000124762,ENSG00000136754,ENSG00000136997,ENSG00000137497,ENSG00000139687,ENSG00000140464,ENSG00000143379,ENSG00000147130,ENSG00000147889,ENSG00000148516,ENSG00000159216,ENSG00000161405,ENSG00000161547,ENSG00000171843,ENSG00000065328,ENSG00000103479",Original,G1 Therapeutics,CDK4 and CDK6 kinase inhibitor,Oncology,Chemotherapy-induced myelosuppression,myelosuppression; small cell lung carcinoma,"EFO_0007053,EFO_0000702",NA,Original,Serious,"P,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4298047,2020,Monjuvi,Tafasitamab,TAFASITAMAB,ENSG00000177455,NA,Original,MorphoSys,CD19-directed mAb,Oncology,DLBCL,diffuse large b-cell lymphoma,EFO_0000403,EFO_1001938,Related,Serious,"P,O,B,A,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL2364655,2015,Repatha,Evolocumab,EVOLOCUMAB,ENSG00000169174,ENSG00000130164,Interactor,Amgen,PCSK9 inhibitor,Other indication,LDL lowering,LDL cholesterol change measurement,EFO_0007804,NA,Original,Not serious,"S,O",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2105737,2015,Odomzo,Sonidegib,SONIDEGIB,ENSG00000128602,ENSG00000185920,Original,Novartis,Smoothened inhibitor,Oncology,Basal cell carcinoma,basal cell carcinoma,EFO_0004193,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL502835,2014,Ofev,Nintedanib,NINTEDANIB,"ENSG00000102755,ENSG00000037280,ENSG00000128052,ENSG00000066468,ENSG00000077782,ENSG00000160867,ENSG00000134853,ENSG00000113721,ENSG00000068078","ENSG00000102678,ENSG00000111679,ENSG00000125968,ENSG00000197461,ENSG00000140320",Interactor,Boehringer Ingelheim,"Kinase inhibitor against PDGFRs, FGFRs, VEGFRs and FLT3",Other indication,IPF (idiopathic pulmonary fibrosis),idiopathic pulmonary fibrosis,EFO_0000768,NA,Original,Serious,"P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3989986,2018,Ultomiris,Ravulizumab,RAVULIZUMAB,ENSG00000106804,ENSG00000244414,Interactor,Alexion,Complement inhibitor,Other indication,"Paroxysmal nocturnal haemoglobinuria, atypical hemolytic uremic syndrome (*), generalized myasthenia gravis AChR+ (*)","paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, Myasthenia gravis","MONDO_0100244,MONDO_0016244,EFO_0004991",NA,Related,Serious,"S,O",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL1743081,2021,Adbry,Tralokinumab,Tralokinumab,ENSG00000169194,"ENSG00000123496,ENSG00000131724,NA",Original,LEO Pharma,IL-13-targeted mAb,Other indication,Atopic dermatitis,atopic eczema,EFO_0000274,"HP_0000964,MONDO_0002406",Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297566,2021,Amondys 45,Casimersen,Casimersen,ENSG00000198947,"ENSG00000101400,NA",Original,Sarepta,Exon 45-skipping ASO,Other indication,DMD,Duchenne muscular dystrophy,MONDO_0010679,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297526,2020,Byfavo,Remimazolam,REMIMAZOLAM,"ENSG00000102287,ENSG00000163288,ENSG00000186297,ENSG00000145864,ENSG00000113327,ENSG00000011677,ENSG00000094755,ENSG00000163285,ENSG00000151834,ENSG00000109158,ENSG00000268089,ENSG00000187730,ENSG00000182256,ENSG00000022355,ENSG00000145863,ENSG00000166206",NA,Original,Acacia,Benzodiazepine,Other indication,Procedural sedation,sedation,EFO_0009868,EFO_0003843,Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3990033,2021,Leqvio,Inclisiran,Inclisiran,ENSG00000169174,"ENSG00000130164,ENSG00000169174",Original,Novartis/Alnylam,PCSK9-targeted siRNA,Other indication,HeFH or ASCVD,coronary atherosclerosis,MONDO_0021661,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL180022,2017,Nerlynx,Neratinib,NERATINIB,"ENSG00000178568,ENSG00000146648,ENSG00000141736","ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000105976,ENSG00000110395,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141736,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000153707,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000165731,ENSG00000168036,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122,ENSG00000198561,ENSG00000254087",Original,Puma Biotechnology,"EGFR, HER2 and HER4 irreversible kinase inhibitor",Oncology,HER2-overexpressed breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL3544914,CHEMBL4298128,CHEMBL2010601",2019,Trikafta,"Tezacaftor, elexacaftor, ivacaftor","TEZACAFTOR,ELEXACAFTOR,IVACAFTOR","ENSG00000001626,ENSG00000001626,ENSG00000001626","ENSG00000001626,ENSG00000001626,ENSG00000001626,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972",Original,Vertex,Two CFTR correctors and a CFTR potentiator,Other indication,Most common gene mutation that causes cystic fibrosis,cystic fibrosis,MONDO_0009061,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4650319,2021,Exkivity,Mobocertinib,Mobocertinib,ENSG00000146648,"ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000080824,ENSG00000081237,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000153707,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000071051,ENSG00000071537,ENSG00000087586,ENSG00000088930,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729",Original,Takeda,EGFR kinase inhibitor,Oncology,EGFR exon 20-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2105760,2015,Rexulti,Brexpiprazole,BREXPIPRAZOLE,"ENSG00000149295,ENSG00000178394,ENSG00000102468","ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000077782,ENSG00000149295",Original,Otsuka,Atypical antipsychotic,Other indication,MDD and schizophrenia,major depressive disorder; schizophrenia,"MONDO_0002009,MONDO_0005090",NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2107831,2018,Mulpleta,Lusutrombopag,LUSUTROMBOPAG,ENSG00000117400,"NA,ENSG00000096968",Original,Shionogi,Thrombopoietin receptor agonist,Other indication,Thrombocytopenia,thrombocytopenia,HP_0001873,NA,Original,Not concordant,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297339,2020,Copper dotatate Cu-64,Copper dotatate Cu-64,COPPERDOTATATECU-64,ENSG00000180616,ENSG00000145675,Interactor,Radiomedix,Radioactive diagnostic,Other indication,"Imaging, cancer",neuroendocrine neoplasm,EFO_1001901,NA,Original,Serious,"P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2103873,2013,Opsumit,Macitentan,MACITENTAN,"ENSG00000136160,ENSG00000151617",NA,Original,Actelion,Endothelin receptor antagonist,Other indication,Pulmonary arterial hypertension,pulmonary arterial hypertension,EFO_0001361,EFO_0000537,Related,Serious,"S,O",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL4594505,2022,Tecvayli,Teclistamab,Teclistamab,"ENSG00000048462,ENSG00000160654,ENSG00000198851,ENSG00000167286","ENSG00000126777,ENSG00000115085,ENSG00000213658,ENSG00000158092,ENSG00000169550",Interactor,J&J,BCMA _ CD3 bispecific antibody,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Related,Serious,"P,O,B,A",TRUE,TRUE,TRUE,TRUE,FALSE
"CHEMBL2010601,CHEMBL2103870",2015,Orkambi,"Ivacaftor, lumacaftor","IVACAFTOR,LUMACAFTOR","ENSG00000001626,ENSG00000001626","ENSG00000001626,ENSG00000001626,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972",Original,Vertex,CFTR potentiator plus CFTR corrector,Other indication,Cystic fibrosis in patients with homozygous DF508 CFTR mutation,cystic fibrosis,MONDO_0009061,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3301582,2019,Polivy,Polatuzumab vedotin,POLATUZUMABVEDOTIN,"ENSG00000198033,ENSG00000167552,ENSG00000261456,ENSG00000176014,ENSG00000258947,ENSG00000123416,ENSG00000101162,ENSG00000188229,ENSG00000152086,ENSG00000007312,ENSG00000137285,ENSG00000167553,ENSG00000196230,ENSG00000137267,ENSG00000127824,ENSG00000104833","ENSG00000007312,ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218",Original,Roche,CD79b-directed ADC,Oncology,Diffuse large B-cell lymphoma,diffuse large b-cell lymphoma,EFO_0000403,EFO_1001938,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL259571,2022,Vtama,Tapinarof,Tapinarof,ENSG00000106546,NA,Original,Dermavant,Aryl hydrocarbon receptor agonist,Other indication,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,EFO_0000676,Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL2141296,2015,Ninlaro,Ixazomib,IXAZOMIB,"ENSG00000165916,ENSG00000240065,ENSG00000159377,ENSG00000108671,ENSG00000100804,ENSG00000161057,ENSG00000154611,ENSG00000159352,ENSG00000100902,ENSG00000013275,ENSG00000173692,ENSG00000101182,ENSG00000103035,ENSG00000129084,ENSG00000142507,ENSG00000222028,ENSG00000197170,ENSG00000175166,ENSG00000205220,ENSG00000100764,ENSG00000277791,ENSG00000136930,ENSG00000099341,ENSG00000163636,ENSG00000185627,ENSG00000127922,ENSG00000115233,ENSG00000087191,ENSG00000108344,ENSG00000204264,ENSG00000100519,ENSG00000100567,ENSG00000143106,ENSG00000126067,ENSG00000130706,ENSG00000106588,ENSG00000008018,ENSG00000041357","ENSG00000068078,ENSG00000136997,ENSG00000072062,ENSG00000073584,ENSG00000076242,ENSG00000084676,ENSG00000089280,ENSG00000091831,ENSG00000099956,ENSG00000100644,ENSG00000113916,ENSG00000124762,ENSG00000135363,ENSG00000136936,ENSG00000139618,ENSG00000139687,ENSG00000140262,ENSG00000141985,ENSG00000146648,ENSG00000161405,ENSG00000163161,ENSG00000163513,ENSG00000171723,ENSG00000179218,ENSG00000179348,ENSG00000185811,ENSG00000186575,ENSG00000204713,ENSG00000204843,ENSG00000082512,ENSG00000112182,ENSG00000123143,ENSG00000124508,ENSG00000134504,ENSG00000142192,ENSG00000162924,ENSG00000167604,ENSG00000197943,ENSG00000100906,ENSG00000131323,ENSG00000057663,ENSG00000168404,ENSG00000013275,ENSG00000087191,ENSG00000100567,ENSG00000101182,ENSG00000138443,ENSG00000147010,ENSG00000148082,ENSG00000150991,ENSG00000161057,ENSG00000186153,ENSG00000197170,ENSG00000240065,ENSG00000276293",Original,Takeda,Oral proteasome inhibitor,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545131,2020,Sarclisa,Isatuximab,ISATUXIMAB,ENSG00000004468,NA,Original,Sanofi,CD38-directed mAb,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Related,Serious,"S,O",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3545191,2021,Evkeeza,Evinacumab,Evinacumab,ENSG00000132855,ENSG00000175445,Original,Regeneron,ANGPTL3-targeted mAb,Other indication,HoFH,homozygous familial hypercholesterolemia,MONDO_0018328,EFO_0004611,Original,Serious,"P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL110458,2018,Galafold,Migalastat,MIGALASTAT,ENSG00000102393,NA,Original,Amicus Therapeutics,beta-galactosidase regulator,Other indication,Fabry disease,fabry disease,MONDO_0010526,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1173655,2013,Gilotrif,Afatinib,AFATINIB,"ENSG00000141736,ENSG00000146648,ENSG00000178568","ENSG00000105976,ENSG00000141736,ENSG00000146648,ENSG00000157168,ENSG00000165731,ENSG00000178568,ENSG00000039068,ENSG00000044115,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000092820,ENSG00000096384,ENSG00000096968,ENSG00000097007,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000132155,ENSG00000133124,ENSG00000134853,ENSG00000135605,ENSG00000137193,ENSG00000138363,ENSG00000138698,ENSG00000141968,ENSG00000142208,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000152894,ENSG00000153201,ENSG00000153707,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168036,ENSG00000168610,ENSG00000179295,ENSG00000182511,ENSG00000185338,ENSG00000185499,ENSG00000197122,ENSG00000198561,ENSG00000254087,ENSG00000075624,ENSG00000160691,ENSG00000172757,ENSG00000177885,ENSG00000115904,ENSG00000044574,ENSG00000101336,ENSG00000110711,ENSG00000117450,ENSG00000126581,ENSG00000196154,ENSG00000136205,ENSG00000067182,ENSG00000115415,ENSG00000170581,ENSG00000000938,ENSG00000006125,ENSG00000007264,ENSG00000010810,ENSG00000011485,ENSG00000033327,ENSG00000043462,ENSG00000050748,ENSG00000069869,ENSG00000070159,ENSG00000071051,ENSG00000071537,ENSG00000074966,ENSG00000078747,ENSG00000087586,ENSG00000088930,ENSG00000090776,ENSG00000092758,ENSG00000099942,ENSG00000100324,ENSG00000100351,ENSG00000100485,ENSG00000101182,ENSG00000102606,ENSG00000103266,ENSG00000105401,ENSG00000105647,ENSG00000107263,ENSG00000107295,ENSG00000107643,ENSG00000109458,ENSG00000109971,ENSG00000113070,ENSG00000113580,ENSG00000115145,ENSG00000115325,ENSG00000117461,ENSG00000120694,ENSG00000123384,ENSG00000123908,ENSG00000124882,ENSG00000126561,ENSG00000127191,ENSG00000127824,ENSG00000127947,ENSG00000131746,ENSG00000132535,ENSG00000134215,ENSG00000136235,ENSG00000137076,ENSG00000137267,ENSG00000137462,ENSG00000137486,ENSG00000138095,ENSG00000138798,ENSG00000140575,ENSG00000140600,ENSG00000141480,ENSG00000141738,ENSG00000142192,ENSG00000142627,ENSG00000142949,ENSG00000144749,ENSG00000145715,ENSG00000146674,ENSG00000147010,ENSG00000149177,ENSG00000149269,ENSG00000149428,ENSG00000151834,ENSG00000154229,ENSG00000158092,ENSG00000158402,ENSG00000159352,ENSG00000160293,ENSG00000161203,ENSG00000166313,ENSG00000166598,ENSG00000167552,ENSG00000169045,ENSG00000169047,ENSG00000169139,ENSG00000169398,ENSG00000170312,ENSG00000171132,ENSG00000173406,ENSG00000174437,ENSG00000174808,ENSG00000176105,ENSG00000178078,ENSG00000183020,ENSG00000184144,ENSG00000188191,ENSG00000189043,ENSG00000196961,ENSG00000197943,ENSG00000198399,ENSG00000198668,ENSG00000213658,ENSG00000253729",Original,Boehringer Ingelheim,"EGFR (ERBB1), HER2 (ERBB2), and HER4 (ERRB4) kinase inhibitor",Oncology,First-line treatment of patients with metastatic NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL43452,2013,Pomalyst,Pomalidomide,POMALIDOMIDE,"ENSG00000167986,ENSG00000139842,ENSG00000113851,ENSG00000100387","ENSG00000113851,ENSG00000106462,ENSG00000138081,ENSG00000185811,ENSG00000113712,ENSG00000130725,ENSG00000109320,ENSG00000115415",Original,Celgene,Immunomodulatory antineoplastic agent,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Original,Serious,"S,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL2106615,CHEMBL1201649",2013,Duavee,"Bazedoxifene acetate, oestrogens","BAZEDOXIFENEACETATE,ESTROGENS,CONJUGATED","ENSG00000091831,ENSG00000140009,ENSG00000140009,ENSG00000091831","ENSG00000012048,ENSG00000171490,ENSG00000012048,ENSG00000171490",Interactor,Pfizer,Conjugated oestrogens with an oestrogen receptor modulator,Other indication,Moderate to Serious vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis,menopause; postmenopausal osteoporosis,"EFO_0003922,EFO_0003854",NA,Original,Not serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2108336,2016,Adlyxin,Lixisenatide,LIXISENATIDE,ENSG00000112164,NA,Original,Sanofi,GLP1 receptor agonist,Other indication,Diabetes,diabetes mellitus,EFO_0000400,NA,Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4298209,2020,Blenrep,Belantamab mafodotin,BELANTAMABMAFODOTIN,"ENSG00000048462,ENSG00000152086,ENSG00000167553,ENSG00000188229,ENSG00000137267,ENSG00000176014,ENSG00000261456,ENSG00000127824,ENSG00000123416,ENSG00000137285,ENSG00000258947,ENSG00000167552,ENSG00000198033,ENSG00000196230,ENSG00000104833,ENSG00000101162","ENSG00000136997,ENSG00000065361,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000146648,ENSG00000179218,ENSG00000204843,ENSG00000084774,ENSG00000133112,ENSG00000142192,ENSG00000114416,ENSG00000163468",Original,GlaxoSmithKline,"BCMA-directed ADC, with microtubule inhibitor",Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3137326,2017,Austedo,Deutetrabenazine,DUTETRABENAZINE,ENSG00000165646,NA,Original,Teva,VMAT2 inhibitor,Other indication,Chorea associated with Huntington disease,chorea; Huntington disease,"EFO_0004152,MONDO_0007739",NA,Original,Serious,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL483254,2015,Farydak,Panobinostat,PANOBINOSTAT,"ENSG00000100429,ENSG00000196591,ENSG00000163517,ENSG00000061273,ENSG00000068024,ENSG00000048052,ENSG00000116478,ENSG00000108840,ENSG00000094631,ENSG00000171720,ENSG00000147099","ENSG00000136997,ENSG00000065361,ENSG00000073614,ENSG00000083799,ENSG00000091831,ENSG00000100697,ENSG00000108654,ENSG00000109906,ENSG00000110092,ENSG00000111642,ENSG00000113916,ENSG00000121741,ENSG00000135363,ENSG00000139687,ENSG00000141027,ENSG00000141510,ENSG00000141736,ENSG00000146648,ENSG00000147130,ENSG00000148400,ENSG00000168036,ENSG00000179348,ENSG00000181163,ENSG00000196498,ENSG00000198795,ENSG00000204209,ENSG00000204713,ENSG00000204843,ENSG00000169554,ENSG00000198176,ENSG00000068024,ENSG00000172936,ENSG00000174197,ENSG00000276903,ENSG00000278677,ENSG00000105287,ENSG00000109320,ENSG00000128340,ENSG00000131910,ENSG00000142599,ENSG00000162924,ENSG00000167604,ENSG00000169083,ENSG00000150991,ENSG00000163468",Original,Novartis,Histone deacetylase inhibitor,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Original,Serious,"P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1743082,2013,Kadcyla,Ado-trastuzumab emtansine,TRASTUZUMABEMTANSINE,"ENSG00000167553,ENSG00000196230,ENSG00000137285,ENSG00000123416,ENSG00000176014,ENSG00000137267,ENSG00000101162,ENSG00000258947,ENSG00000261456,ENSG00000188229,ENSG00000104833,ENSG00000127824,ENSG00000198033,ENSG00000167552,ENSG00000152086,ENSG00000141736","ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000083799,ENSG00000085832,ENSG00000091831,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000126934,ENSG00000127329,ENSG00000130779,ENSG00000135605,ENSG00000136997,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122,ENSG00000204843",Original,Genentech,HER2-targeted antibody and microtubule inhibitor conjugate,Oncology,HER2-positive metastatic breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,NA,Original,Serious,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297590,2022,Quviviq,Daridorexant,Daridorexant,"ENSG00000137252,ENSG00000121764",NA,Original,Idorsia,Orexin receptor antagonist,Other indication,Insomnia,insomnia,EFO_0004698,"EFO_0008568,EFO_0005271",Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3414621,2020,Tazverik,Tazemetostat,TAZEMETOSTAT,ENSG00000106462,NA,Original,Epizyme,EZH2 inhibitor,Oncology,Epithelioid sarcoma,epithelioid sarcoma,MONDO_0017387,EFO_1001968,Related,Serious,"P,O,A,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3989987,2018,Onpattro,Patisiran,PATISIRAN,ENSG00000118271,ENSG00000118271,Original,Alnylam Pharmaceuticals,TTR-directed small interfering RNA,Other indication,Hereditary TTR-mediated amyloidosis,hereditary ATTR amyloidosis,MONDO_0017132,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1568698,2022,Ztalmy,Ganaxolone,Ganaxolone,"ENSG00000094755,ENSG00000163288,ENSG00000102287,ENSG00000166206,ENSG00000145863,ENSG00000022355,ENSG00000113327,ENSG00000187730,ENSG00000011677,ENSG00000268089,ENSG00000145864,ENSG00000151834,ENSG00000186297,ENSG00000182256,ENSG00000109158,ENSG00000163285","ENSG00000166206,ENSG00000022355",Original,Marinus,GABAA receptor positive allosteric modulator,Other indication,Seizures associated with CDD,Epileptic encephalopathy,HP_0200134,NA,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL4594217,CHEMBL2048484",2013,Invokana,Canagliflozin,"CANAGLIFLOZIN,CANAGLIFLOZIN","ENSG00000140675,ENSG00000140675",NA,Original,Janssen,SGLT2 inhibitor,Other indication,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Related,Not concordant,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL4299940,2022,Pyrukynd,Mitapivat,Mitapivat,ENSG00000143627,NA,Original,Agios,Pyruvate kinase activator,Other indication,Haemolytic anaemia due to PK deficiency,hemolytic anemia,EFO_0005558,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2107841,2014,Tanzeum,Albiglutide,ALBIGLUTIDE,ENSG00000112164,NA,Original,GlaxoSmithKline,GLP1-receptor agonist,Other indication,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3301587,2017,Imfinzi,Durvalumab,DURVALUMAB,ENSG00000120217,ENSG00000197646,Original,AstraZeneca,PDL1-blocking antibody,Oncology,Urothelial carcinoma,urothelial carcinoma,EFO_0008528,NA,Original,Serious,"P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3039537,2015,Kanuma,Sebelipase alfa,SEBELIPASEALFA,ENSG00000107798,NA,Original,Alexion,Enzyme replacement therapy,Other indication,LAL deficiency,lysosomal acid lipase deficiency,MONDO_0010204,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2396661,2019,Piqray,Alpelisib,ALPELISIB,ENSG00000121879,"ENSG00000121879,ENSG00000065361,ENSG00000145675,ENSG00000117461,ENSG00000124788,ENSG00000169047,ENSG00000066427,ENSG00000100368,ENSG00000177885",Original,Novartis,PI3K inhibitor,Oncology,Breast cancer,breast cancer,MONDO_0007254,NA,Original,Serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL3544914,CHEMBL2010601",2018,Symdeko,"Tezacaftor, ivacaftor","TEZACAFTOR,IVACAFTOR","ENSG00000001626,ENSG00000001626","ENSG00000001626,ENSG00000001626,ENSG00000170421,ENSG00000253729,ENSG00000170421,ENSG00000253729,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972,ENSG00000104783,ENSG00000132912,ENSG00000174502,ENSG00000240972",Original,Vertex Pharmaceuticals,CFTR corrector and CFTR potentiator,Other indication,Cystic fibrosis,cystic fibrosis,MONDO_0009061,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1743087,2014,Entyvio,Vedolizumab,VEDOLIZUMAB,"ENSG00000115232,ENSG00000139626","ENSG00000139626,ENSG00000115232,ENSG00000136754",Original,Takeda,Integrin-receptor antagonist,Other indication,Ulcerative colitis and Crohn's disease,ulcerative colitis; Crohn's disease,"EFO_0000729,EFO_0000384",NA,Original,Serious,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3590187,2020,Winlevi,Clascoterone,CLASCOTERONE,ENSG00000169083,"ENSG00000107338,ENSG00000110092,ENSG00000116288",Interactor,Cassiopea SpA,Androgen receptor inhibitor,Other indication,Acne vulgaris,acne,EFO_0003894,NA,Original,Not serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL1743070,2014,Sylvant,Siltuximab,SILTUXIMAB,ENSG00000136244,NA,Original,Janssen Biotech,IL-6-specific antibody,Other indication,Multicentric Castleman's disease,Castleman disease,MONDO_0015564,NA,Original,Serious,"P,O",FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL2181927,2021,Kerendia,Finerenone,Finerenone,ENSG00000151623,NA,Original,Bayer,Non-steroidal MR antagonist,Other indication,CKD with type 2 diabetes,chronic kidney disease,EFO_0003884,HP_0012594,Related,Serious,"P,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL521686,2014,Lynparza,Olaparib,OLAPARIB,"ENSG00000143799,ENSG00000041880,ENSG00000129484","ENSG00000141510,ENSG00000082805,ENSG00000091831,ENSG00000100030,ENSG00000148737,ENSG00000154767,ENSG00000156052,ENSG00000157554,ENSG00000164305,ENSG00000165392,ENSG00000168036,ENSG00000198900,ENSG00000245848,ENSG00000286522,ENSG00000004700,ENSG00000101412,ENSG00000148702,ENSG00000073050,ENSG00000092847,ENSG00000118518,ENSG00000131747,ENSG00000143799,ENSG00000147874,ENSG00000150991,ENSG00000166884,ENSG00000189403,ENSG00000196419,ENSG00000253729",Original,AstraZeneca,PARP inhibitor,Oncology,Advanced BRCA-mutated ovarian cancer,ovarian cancer,MONDO_0008170,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL827,CHEMBL4301162",2021,Azstarys,"Dexmethylphenidate, serdexmethylphenidate","Dexmethylphenidate,serdexmethylphenidate","ENSG00000103546,ENSG00000142319,ENSG00000142319,ENSG00000103546","NA,NA,ENSG00000149295,ENSG00000152214,ENSG00000149295,ENSG00000152214",Original,Commave Therapeutics,CNS stimulant,Other indication,ADHD,attention deficit hyperactivity disorder,EFO_0003888,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2364649,2020,Margenza,Margetuximab,MARGETUXIMAB,ENSG00000141736,"ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000197122",Original,MacroGenics,HER2-directed mAb,Oncology,HER2-positive breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,NA,Original,Serious,"S,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2216870,2014,Zydelig,Idelalisib,IDELALISIB,ENSG00000171608,"ENSG00000145675,NA",Original,Gilead Sciences,PI3K‚Äöp110-delta subunit inhibitor,Other indication,"CLL, B-cell non-Hodgkin lymphoma and SLL",chronic lymphocytic leukemia; B-cell non-Hodgkins lymphoma,"EFO_0000095,EFO_1001938",NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2219425,2015,Aristada,Aripiprazole lauroxil,ARIPIPRAZOLELAUROXIL,"ENSG00000102468,ENSG00000178394,ENSG00000149295","ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000077782,ENSG00000149295",Original,Alkermes,Extended release atypical antipsychotic,Other indication,Schizophrenia,schizophrenia,MONDO_0005090,NA,Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1742992,2014,Blincyto,Blinatumomab,BLINATUMOMAB,"ENSG00000177455,ENSG00000160654,ENSG00000167286,ENSG00000198851",NA,Original,Amgen,CD19- and CD3-bispecific antibody,Oncology,B-ALL,precursor B-cell acute lymphoblastic leukemia,MONDO_0020511,EFO_1001938,Related,Serious,"P,O,B,A",TRUE,FALSE,TRUE,FALSE,FALSE
"CHEMBL3137301,CHEMBL1069",2015,Entresto,"Sacubitril, valsartan","SACUBITRIL,VALSARTAN","ENSG00000196549,ENSG00000144891",ENSG00000134817,Interactor,Novartis,A neprilysin inhibitor plus an angiotensin II receptor blocker,Other indication,Chronic heart failure,congestive heart failure,EFO_0000373,NA,Original,Serious,"P,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3707276,2021,Voxzogo,Vosoritide,Vosoritide,ENSG00000159899,NA,Original,Biomarin,CNP analogue,Other indication,Achondroplasia,achondroplasia,MONDO_0007037,"EFO_0004339,Orphanet_329191",Original,Not serious,"P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1289494,2021,Fotivda,Tivozanib,Tivozanib,"ENSG00000102755,ENSG00000128052,ENSG00000037280,ENSG00000157404,ENSG00000113721","ENSG00000037280,ENSG00000081237,ENSG00000096384,ENSG00000097007,ENSG00000100311,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000111679,ENSG00000124181,ENSG00000127329,ENSG00000128052,ENSG00000134853,ENSG00000135605,ENSG00000143322,ENSG00000145675,ENSG00000152894,ENSG00000165025,ENSG00000171862,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000197122,ENSG00000254087,ENSG00000134215,ENSG00000010810,ENSG00000094796,ENSG00000101336,ENSG00000164916,ENSG00000177885,ENSG00000186432,ENSG00000205439",Original,Aveo,VEGFR kinase inhibitor,Oncology,Renal cell carcinoma,renal cell carcinoma,EFO_0000681,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4594350,2022,Krazati,Adagrasib,Adagrasib,ENSG00000133703,"ENSG00000078061,ENSG00000133703,ENSG00000157764,ENSG00000067560,ENSG00000132155,ENSG00000142192,ENSG00000143398",Original,Mirati,KRAS-G12C inhibitor,Oncology,KRASG12C-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"S,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3990029,2019,Skyrizi,Risankizumab,RISANKIZUMAB,"ENSG00000110944,ENSG00000113302","ENSG00000110944,ENSG00000113302,ENSG00000162594",Original,AbbVie,IL-23 antagonist,Other indication,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,EFO_0000676,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL408513,2014,Beleodaq,Belinostat,BELINOSTAT,"ENSG00000108840,ENSG00000147099,ENSG00000061273,ENSG00000068024,ENSG00000171720,ENSG00000094631,ENSG00000163517,ENSG00000048052,ENSG00000100429,ENSG00000196591,ENSG00000116478","ENSG00000065361,ENSG00000100697,ENSG00000107485,ENSG00000113916,ENSG00000127152,ENSG00000141027,ENSG00000141510,ENSG00000141736,ENSG00000146648,ENSG00000147130,ENSG00000148400,ENSG00000162367,ENSG00000168036,ENSG00000169083,ENSG00000177565,ENSG00000181163,ENSG00000181449",Interactor,Spectrum,Histone-deacetylase inhibitor,Other indication,Peripheral T-cell lymphoma,unspecified peripheral T-cell lymphoma,EFO_0000211,NA,Original,Serious,"P,O,A,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL512351,2017,Bevyxxa,Betrixaban,BETRIXABAN,ENSG00000126218,"ENSG00000117601,NA",Original,Portola Pharmaceuticals,FXa inhibitor,Other indication,Prophylaxis of venous thromboembolism,venous thromboembolism,EFO_0004286,NA,Original,Serious,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297788,2022,Lunsumio,Mosunetuzumab,Mosunetuzumab,"ENSG00000167286,ENSG00000156738,ENSG00000198851,ENSG00000160654",NA,Original,Roche/Genentech,CD20 _ CD3 bispecific antibody,Oncology,Follicular lymphoma,follicular lymphoma,MONDO_0018906,EFO_0000183,Related,Serious,"P,O,B,A",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL4594261,2020,Fluoroestradiol F-18,Fluoroestradiol F-18,FLUOROESTRADIOLF-18,ENSG00000186868,"ENSG00000096384,ENSG00000108953,ENSG00000110367,ENSG00000118515,ENSG00000142208,ENSG00000146648,ENSG00000153944,ENSG00000197122,ENSG00000204843,ENSG00000075624,ENSG00000109971,ENSG00000134516,ENSG00000135097,ENSG00000186868,ENSG00000082701,ENSG00000105723,ENSG00000004478,ENSG00000010810,ENSG00000100784,ENSG00000108443,ENSG00000117676,ENSG00000142192,ENSG00000142330,ENSG00000164885,ENSG00000164924,ENSG00000165732,ENSG00000166033,ENSG00000167552,ENSG00000170027,ENSG00000175166,ENSG00000175203,ENSG00000175793,ENSG00000177189,ENSG00000185624,ENSG00000188906",Original,Zionexa,Radioactive diagnostic,Other indication,"Imaging, breast cancer",breast carcinoma,EFO_0000305,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4435170,2022,Sotyktu,Deucravacitinib,Deucravacitinib,ENSG00000105397,ENSG00000170581,Original,Bristol Myers Squibb,TYK2 inhibitor,Other indication,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,EFO_0000676,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3833393,2017,Hemlibra,Emicizumab,EMICIZUMAB,"ENSG00000126218,ENSG00000101981","ENSG00000185010,ENSG00000117601",Original,Roche/Genentech,Bispecific FIX and FX-directed antibody,Other indication,Haemophilia A,hemophilia A,MONDO_0010602,NA,Original,Serious,"P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297335,2020,PSMA-11 Ga-68,PSMA-11 Ga-68,PSMA-11GA-68,ENSG00000142515,ENSG00000169083,Original,UCLA,Radioactive diagnostic,Other indication,"Imaging, prostate cancer",prostate carcinoma,EFO_0001663,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4594511,2022,Amvuttra,Vutrisiran,Vutrisiran,ENSG00000118271,ENSG00000118271,Original,Alnylam,TTR-targeted siRNA,Other indication,Polyneuropathy of hereditary TTR-mediated amyloidosis,familial amyloid neuropathy,EFO_0004129,NA,Original,Serious,"S,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2104993,2013,Brintellix,Vortioxetine,VORTIOXETINE,"ENSG00000178394,ENSG00000108576,ENSG00000166736",NA,Original,Takeda,Serotonin reuptake inhibitor,Other indication,Major depressive disorder,major depressive disorder,MONDO_0002009,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3990026,2018,Revcovi,Elapegademase,ELAPEGADEMASE,ENSG00000196839,NA,Original,Leadiant Biosciences,Recombinant adenosine deaminase,Other indication,ADA-SCID,"Serious combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency",MONDO_0007064,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3301612,2018,Braftovi,Encorafenib,ENCORAFENIB,ENSG00000157764,"ENSG00000126934,ENSG00000132155,ENSG00000157764,ENSG00000169032,ENSG00000213281,ENSG00000078061,ENSG00000095015,ENSG00000096384,ENSG00000108953,ENSG00000133703,ENSG00000174775,ENSG00000105401,ENSG00000109971,ENSG00000166913,ENSG00000171132",Original,Array BioPharma,BRAF inhibitor,Oncology,BRAF-mutated melanoma,melanoma,EFO_0000756,NA,Original,Serious,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2107830,2014,Jardiance,Empagliflozin,EMPAGLIFLOZIN,ENSG00000140675,NA,Original,Boehringer Ingelheim,SGLT2 inhibitor,Other indication,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Related,Not concordant,"S,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL1743043,2018,Lumoxiti,Moxetumomab pasudotox,MOXETUMOMABPASUDOTOX,"ENSG00000167658,ENSG00000012124","ENSG00000111679,ENSG00000165025",Interactor,AstraZeneca,CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate,Oncology,Hairy cell leukaemia,hairy cell leukemia,EFO_1000956,NA,Original,Serious,"P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4297844,2019,Enhertu,Trastuzumab deruxtecan,TRASTUZUMABDERUXTECAN,"ENSG00000141736,ENSG00000198900","ENSG00000015285,ENSG00000065361,ENSG00000072274,ENSG00000080824,ENSG00000081237,ENSG00000082898,ENSG00000085832,ENSG00000091831,ENSG00000096384,ENSG00000097007,ENSG00000101213,ENSG00000111252,ENSG00000113263,ENSG00000116560,ENSG00000122566,ENSG00000123983,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000136997,ENSG00000141736,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000147140,ENSG00000152894,ENSG00000153201,ENSG00000157168,ENSG00000162434,ENSG00000163399,ENSG00000165025,ENSG00000168610,ENSG00000178568,ENSG00000179295,ENSG00000181163,ENSG00000197122",Original,Daiichi Sankyo/AstraZeneca,HER2-directed ADC,Oncology,HER2-positive breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,NA,Original,Serious,"P,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108730,2017,Kevzara,Sarilumab,SARILUMAB,ENSG00000160712,"NA,ENSG00000136244",Original,Sanofi/Regeneron,IL-6 receptor antagonist,Other indication,Rheumatoid arthritis,rheumatoid arthritis,EFO_0000685,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3301622,2018,Xospata,Gilteritinib,GILTERITINIB,"ENSG00000122025,ENSG00000167601","ENSG00000122025,ENSG00000096384,ENSG00000097007,ENSG00000124181,ENSG00000143322,ENSG00000145675,ENSG00000146648,ENSG00000165025,ENSG00000179295,ENSG00000182866,ENSG00000145715,ENSG00000106070",Original,Astellas,FLT3 inhibitor,Oncology,FLT3-positive AML,acute myeloid leukemia,EFO_0000222,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2103875,2013,Mekinist,Trametinib,TRAMETINIB,"ENSG00000169032,ENSG00000126934",NA,Original,GSK,MEK1 and MEK2 kinase inhibitor,Oncology,Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test,metastatic melanoma,EFO_0002617,EFO_0000756,Related,Serious,"S,O,F",TRUE,FALSE,TRUE,FALSE,FALSE
"CHEMBL1473,CHEMBL1198857",2013,Breo Ellipta,"Fluticasone, vilanterol","FLUTICASONE,VILANTEROL","ENSG00000113580,ENSG00000169252","ENSG00000204388,ENSG00000204389,NA,ENSG00000113369,ENSG00000163485,ENSG00000080824,ENSG00000175793",Original,GSK,Corticosteroid plus LABA,Other indication,Chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO_0000341,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3655081,2022,Cibinqo,Abrocitinib,Abrocitinib,ENSG00000162434,"ENSG00000134352,ENSG00000115415,ENSG00000159110",Interactor,Pfizer,JAK inhibitor,Other indication,Atopic dermatitis,atopic eczema,EFO_0000274,"HP_0000964,MONDO_0002406",Related,Not serious,"P,B",TRUE,TRUE,TRUE,TRUE,FALSE
CHEMBL1743048,2013,Gazyva,Obinutuzumab,OBINUTUZUMAB,ENSG00000156738,"ENSG00000157613,ENSG00000168685",Interactor,Genentech,Humanized CD20-specific monoclonal antibody,Oncology,Previously untreated chronic lymphocytic leukaemia,chronic lymphocytic leukemia,EFO_0000095,NA,Original,Serious,"P,O,B",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2178422,2020,Nurtec ODT,Rimegepant,RIMEGEPANT,ENSG00000064989,ENSG00000110680,Interactor,Biohaven,CGRP receptor antagonist,Other indication,Migraine,migraine disorder,MONDO_0005277,NA,Original,Not serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3545185,2019,Xpovio,Selinexor,SELINEXOR,ENSG00000082898,"ENSG00000141510,ENSG00000141736,NA",Original,Karyopharm Therapeutics,XPO1 inhibitor,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108611,2017,Besponsa,Inotuzumab ozogamicin,INOTUZUMABOZOGAMICIN,ENSG00000012124,NA,Original,Pfizer,CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate,Oncology,B cell precursor ALL,precursor B-cell acute lymphoblastic leukemia,MONDO_0020511,EFO_1001938,Related,Serious,"P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL1743010,2015,Empliciti,Elotuzumab,ELOTUZUMAB,ENSG00000026751,ENSG00000183918,Interactor,Bristol-Myers Squibb,SLAMF7-directed mAb,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Original,Serious,"P,O,B",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL1983350,2018,Diacomit,Stiripentol,STIRIPENTOL,ENSG00000022355,"ENSG00000113327,NA",Original,Biocodex,GABA reuptake inhibitor,Other indication,Dravet syndrome,dravet syndrome,Orphanet_33069,"MONDO_0020072,MONDO_0020072",Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1201605,2016,Zinbryta,Daclizumab,DACLIZUMAB,"ENSG00000134460,ENSG00000100385,ENSG00000147168","ENSG00000134470,ENSG00000244411",Original,Biogen,IL-2-targeted mAb,Other indication,Multiple sclerosis,multiple sclerosis,MONDO_0005301,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3188267,2020,Tabrecta,Capmatinib,CAPMATINIB,ENSG00000105976,"ENSG00000105976,ENSG00000146648,ENSG00000010671,ENSG00000081237,ENSG00000101213,ENSG00000110395,ENSG00000111252,ENSG00000113263,ENSG00000124181,ENSG00000127329,ENSG00000135605,ENSG00000140538,ENSG00000143322,ENSG00000145675,ENSG00000152894,ENSG00000165025,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000185338,ENSG00000197122,ENSG00000254087,ENSG00000160691,ENSG00000177885,ENSG00000101336,ENSG00000136205,ENSG00000000938,ENSG00000007264,ENSG00000010017,ENSG00000019991,ENSG00000070159,ENSG00000071051,ENSG00000074966,ENSG00000105647,ENSG00000115290,ENSG00000117461,ENSG00000127947,ENSG00000131746,ENSG00000134215,ENSG00000141738,ENSG00000145715,ENSG00000149177,ENSG00000158092,ENSG00000160293,ENSG00000176105,ENSG00000197943,ENSG00000198753",Original,Novartis,MET kinase inhibitor,Oncology,NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297762,2019,Vyondys 53,Golodirsen,GOLODIRSEN,ENSG00000198947,"ENSG00000101400,NA",Original,Sarepta,Exon 53 skipping antisense,Other indication,Duchenne muscular dystrophy,duchenne muscular dystrophy,MONDO_0010679,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707358,2022,Xenpozyme,Olipudase alfa,Olipudasealfa,ENSG00000166311,NA,Original,Sanofi/Genzyme,Acid sphingomyelinase ERT,Other indication,Acid sphingomyelinase deficiency,acid sphingomyelinase deficiency,MONDO_0100464,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545132,2022,Elahere,Mirvetuximab soravtansine,Mirvetuximabsoravtansine,"ENSG00000110195,ENSG00000127824,ENSG00000152086,ENSG00000261456,ENSG00000101162,ENSG00000188229,ENSG00000104833,ENSG00000258947,ENSG00000123416,ENSG00000198033,ENSG00000167553,ENSG00000137285,ENSG00000167552,ENSG00000176014,ENSG00000137267,ENSG00000196230","ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218,ENSG00000204843,ENSG00000123349",Interactor,ImmunoGen,FR_-targeted antibody-drug conjugate,Oncology,Ovarian cancer,ovarian carcinoma,EFO_0001075,NA,Original,Serious,"P,O,A,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3989977,2018,Gamifant,Emapalumab,EMAPALUMAB,ENSG00000111537,ENSG00000027697,Original,Novimmune,Interferon-‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢‚Äö√Ñ¬¢-blocking antibody,Other indication,Primary haemophagocytic lymphohistiocytosis,genetic hemophagocytic lymphohistiocytosis,MONDO_0015541,NA,Original,Serious,"P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297185,2019,Nubeqa,Darolutamide,DAROLUTAMIDE,ENSG00000169083,"ENSG00000169083,ENSG00000005339,ENSG00000010671,ENSG00000084676,ENSG00000089280,ENSG00000097007,ENSG00000101213,ENSG00000106462,ENSG00000109685,ENSG00000110092,ENSG00000118058,ENSG00000124181,ENSG00000129514,ENSG00000136504,ENSG00000136826,ENSG00000140396,ENSG00000141027,ENSG00000141867,ENSG00000141968,ENSG00000143322,ENSG00000145675,ENSG00000157554,ENSG00000159388,ENSG00000165025,ENSG00000167548,ENSG00000168036,ENSG00000179295,ENSG00000182511,ENSG00000182866,ENSG00000184634,ENSG00000197122,ENSG00000204209,ENSG00000254087,ENSG00000125686,ENSG00000142515,ENSG00000145715,ENSG00000160691,ENSG00000266412",Original,Bayer,Androgen receptor inhibitor,Oncology,Prostate cancer,prostate cancer,MONDO_0008315,NA,Original,Serious,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL471737,2015,Corlanor,Ivabradine,IVABRADINE,ENSG00000138622,ENSG00000138622,Original,Amgen,Hyperpolarization-activated cyclic nucleotide-gated channel blocker,Other indication,Chronic heart failure,Abnormality of the cardiovascular system,HP_0001626,NA,Original,Serious,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL566752,2014,Neuraceq,Florbetaben-F18,FLORBETABEN-F18,ENSG00000142192,"ENSG00000080815,ENSG00000130203,ENSG00000137642,ENSG00000137845,ENSG00000142192,ENSG00000143801,ENSG00000186868,ENSG00000070808,ENSG00000132535,ENSG00000007047,ENSG00000073060,ENSG00000120885,ENSG00000120899,ENSG00000121653,ENSG00000128482,ENSG00000129219,ENSG00000131042,ENSG00000138613,ENSG00000139318,ENSG00000163879,ENSG00000165916,ENSG00000168077",Original,Piramal Imaging,Radioactive diagnostic agent,Other indication,Imaging of the brain to estimate density of neuritic amyloid-beta plaques,neuritic plaque measurement; Alzheimer disease,"EFO_0006798,MONDO_0004975",NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545376,2019,Balversa,Erdafitinib,ERDAFITINIB,"ENSG00000077782,ENSG00000066468,ENSG00000160867,ENSG00000068078","ENSG00000065361,ENSG00000068078,ENSG00000002834,ENSG00000039068,ENSG00000066468,ENSG00000077782,ENSG00000096384,ENSG00000099956,ENSG00000102145,ENSG00000106462,ENSG00000107485,ENSG00000123388,ENSG00000124181,ENSG00000124762,ENSG00000127914,ENSG00000136997,ENSG00000139219,ENSG00000145675,ENSG00000147548,ENSG00000160867,ENSG00000165731,ENSG00000168036,ENSG00000168769,ENSG00000177606,ENSG00000178104,ENSG00000179094,ENSG00000179295,ENSG00000179348,ENSG00000184937,ENSG00000197157,ENSG00000106615",Original,Janssen /J&J,FGFR inhibitor,Oncology,Bladder cancer,urinary bladder carcinoma,MONDO_0004986,NA,Original,Serious,"P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4216467,2020,Qinlock,Ripretinib,RIPRETINIB,"ENSG00000157404,ENSG00000134853","NA,ENSG00000111252,ENSG00000113721,ENSG00000146648,ENSG00000049130",Original,Deciphera,KIT and PDGFRA kinase inhibitor,Oncology,GIST,gastrointestinal stromal tumor,MONDO_0011719,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1094636,2017,Zejula,Niraparib,NIRAPARIB,"ENSG00000129484,ENSG00000143799","ENSG00000141510,ENSG00000082805,ENSG00000091831,ENSG00000100030,ENSG00000148737,ENSG00000154767,ENSG00000156052,ENSG00000157554,ENSG00000164305,ENSG00000165392,ENSG00000168036,ENSG00000198900,ENSG00000245848,ENSG00000286522,ENSG00000101412,ENSG00000148702",Interactor,Tesaro,PARP inhibitor,Oncology,"Epithelial ovarian, fallopian tube or primary peritoneal cancer",fallopian tube cancer; ovarian epithelial tumor; primary peritoneal carcinoma,"MONDO_0002158,MONDO_0002229,MONDO_0015686",NA,Original,Serious,"P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3622821,2019,Rinvoq,Upadacitinib,UPADACITINIB,"ENSG00000162434,ENSG00000096968,ENSG00000105397,ENSG00000105639","ENSG00000096968,ENSG00000100368,ENSG00000105639,ENSG00000134352,ENSG00000162434,ENSG00000065361,ENSG00000106541,ENSG00000115415,ENSG00000131196,ENSG00000142166,ENSG00000168610,ENSG00000183386",Original,AbbVie,JAK inhibitor,Other indication,Rheumatoid arthritis,rheumatoid arthritis,EFO_0000685,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3989931,2017,Idhifa,Enasidenib mesylate,ENASIDENIBMESYLATE,ENSG00000182054,ENSG00000182054,Original,Celgene/Agios,IDH2 inhibitor,Oncology,IDH2-mutated AML,acute myeloid leukemia,EFO_0000222,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3948730,2021,Ukoniq,Umbralisib,Umbralisib,"ENSG00000171608,ENSG00000097007,ENSG00000213923","ENSG00000078674,ENSG00000122025,ENSG00000141736,ENSG00000145675,ENSG00000149311,ENSG00000153707,ENSG00000157404,ENSG00000134982,ENSG00000197822",Interactor,TG Therapeutics,PI3Kdelta and CK1epsilon inhibitor,Oncology,"MZL, follicular lymphoma",MZL; follicular lymphoma,"EFO_1000630,MONDO_0018906",EFO_0000183,Related,Serious,"P,O,B,A",TRUE,TRUE,TRUE,TRUE,FALSE
CHEMBL2107884,2016,Cinqair,Reslizumab,RESLIZUMAB,ENSG00000113525,NA,Original,Teva,IL-5 antagonist,Other indication,Serious asthma,Status Asthmaticus,EFO_0008590,"MONDO_0004979,MONDO_0004979",Related,Serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3707328,2018,Emgality,Galcanezumab,GALCANEZUMAB,"ENSG00000175868,ENSG00000110680","ENSG00000157087,ENSG00000110680",Original,Eli Lilly,CGRP antibody,Other indication,Migraine,migraine disorder,MONDO_0005277,NA,Original,Not serious,"S,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108078,2015,Natpara,Parathyroid hormone,PARATHYROIDHORMONE,ENSG00000160801,"ENSG00000152266,ENSG00000087494,ENSG00000168036",Original,NPS Pharma,Hormonal injection,Other indication,Hypocalcaemia in patients with hypoparathyroidism,hypoparathyroidism; Hypocalcemia,"EFO_0009451,HP_0002901",NA,Original,Not concordant,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3989949,2019,Xcopri,Cenobamate,CENOBAMATE,"ENSG00000168356,ENSG00000196876,ENSG00000185313,ENSG00000144285,ENSG00000153253,ENSG00000183873,ENSG00000136531,ENSG00000169432,ENSG00000136546,ENSG00000007314,ENSG00000186297,ENSG00000151834,ENSG00000011677,ENSG00000187730,ENSG00000109158,ENSG00000022355,ENSG00000166206,ENSG00000182256,ENSG00000145864,ENSG00000268089,ENSG00000145863,ENSG00000094755,ENSG00000163288,ENSG00000113327,ENSG00000102287,ENSG00000163285","ENSG00000022355,ENSG00000102466,ENSG00000105711,ENSG00000113327,ENSG00000114279,ENSG00000166206,NA",Original,SK Life Science,Unknown,Other indication,Partial onset seizures,seizure,HP_0001250,NA,Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL408403,2017,Giapreza,Angiotensin II,ANGIOTENSINII,ENSG00000144891,"ENSG00000134817,ENSG00000139053,ENSG00000143153",Interactor,La Jolla Pharmaceutical Company,Synthetic human angiotensin,Other indication,Blood pressure in adults with septic or other distributive shock,septic shock; blood pressure,"EFO_0006834,EFO_0004325",NA,Original,Serious,P,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3286830,2018,Lorbrena,Lorlatinib,LORLATINIB,"ENSG00000171094,ENSG00000143924","ENSG00000165731,ENSG00000171094,ENSG00000096384,ENSG00000107882,ENSG00000127329,ENSG00000149177",Original,Pfizer,ALK and ROS1 inhibitor,Oncology,ALK-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3544921,2017,Brineura,Cerliponase alfa,CERLIPONASEALFA,ENSG00000166340,NA,Original,BioMarin Pharmaceutical,Tripeptidyl peptidase,Other indication,Tripeptidyl peptidase 1 deficiency (neuronal ceroid lipofuscinosis type 2*),neuronal ceroid lipofuscinosis 2,MONDO_0008769,NA,Original,Serious,"P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3301624,2020,Imcivree,Setmelanotide,SETMELANOTIDE,ENSG00000166603,NA,Original,Rhythm,Melanocortin receptor 4 agonist,Other indication,Rare genetic diseases of obesity,Bardet-Biedl syndrome,MONDO_0015229,NA,Original,Serious,"P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3301589,2019,Padcev,Enfortumab vedotin,ENFORTUMABVEDOTIN,"ENSG00000143217,ENSG00000101162,ENSG00000167552,ENSG00000261456,ENSG00000127824,ENSG00000123416,ENSG00000258947,ENSG00000198033,ENSG00000188229,ENSG00000152086,ENSG00000137267,ENSG00000104833,ENSG00000167553,ENSG00000137285,ENSG00000196230,ENSG00000176014","ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218,ENSG00000204843",Interactor,Astellas,Nectin-4-directed ADC,Oncology,Urothelial cancers,urothelial neoplasm,MONDO_0024337,NA,Original,Serious,"P,B,A",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4297756,2018,Ajovy,Fremanezumab,FREMANEZUMAB,"ENSG00000110680,ENSG00000175868","ENSG00000157087,ENSG00000110680",Original,Teva,CGRP antibody,Other indication,Migraine,migraine disorder,MONDO_0005277,NA,Original,Not serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4298185,2021,Skytrofa,Lonapegsomatropin,Lonapegsomatropin,ENSG00000112964,ENSG00000112964,Original,Ascendis Pharma,PEGylated human growth hormone,Other indication,Growth failure due to GHD,Growth delay,HP_0001510,EFO_0004339,Original,Not serious,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297588,2021,Bylvay,Odevixibat,Odevixibat,ENSG00000125255,NA,Original,Albireo,IBAT inhibitor,Other indication,Pruritus in PFIC,familial intrahepatic cholestasis,MONDO_0017290,EFO_0005653,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297340,2019,Gallium dotatoc Ga-68,Gallium dotatoc Ga-68,GALLIUMDOTATOCGA-68,ENSG00000180616,ENSG00000145675,Interactor,UIHC PET Imaging Center,Radioactive diagnostic,Other indication,Localization of somatostatin receptor-positive neuroendocrine tumours,neuroendocrine neoplasm,EFO_1001901,NA,Original,Serious,"S,O",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL1743078,2022,Tzield,Teplizumab,Teplizumab,ENSG00000198851,ENSG00000165025,Interactor,Provention Bio,CD3-targeted antibody,Other indication,Delay onset of type 1 diabetes,type 1 diabetes mellitus,MONDO_0005147,NA,Original,Not concordant,"P,B",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4208229,2021,Scemblix,Asciminib,Asciminib,ENSG00000097007,"ENSG00000122025,ENSG00000149311,ENSG00000157404",Original,Novartis,ABL/BCR-ABL1  kinase inhibitor,Oncology,Ph+ CML,Blast Phase Chronic Myelogenous Leukemia; BCR-ABL1 Positive,EFO_1000131,EFO_0000339,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707247,2020,Zeposia,Ozanimod,OZANIMOD,ENSG00000170989,ENSG00000110848,Interactor,Celgene/Bristol Myers Squibb,S1P receptor modulator,Other indication,Multiple sclerosis,multiple sclerosis,MONDO_0005301,NA,Original,Serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL1852688,2021,Truseltiq,Infigratinib,Infigratinib,"ENSG00000160867,ENSG00000068078,ENSG00000066468,ENSG00000077782","ENSG00000066468,ENSG00000002834,ENSG00000039068,ENSG00000065361,ENSG00000068078,ENSG00000077782,ENSG00000096384,ENSG00000099956,ENSG00000102145,ENSG00000106462,ENSG00000107485,ENSG00000123388,ENSG00000124181,ENSG00000124762,ENSG00000127914,ENSG00000136997,ENSG00000139219,ENSG00000145675,ENSG00000147548,ENSG00000160867,ENSG00000165731,ENSG00000168036,ENSG00000168769,ENSG00000177606,ENSG00000178104,ENSG00000179094,ENSG00000179295,ENSG00000179348,ENSG00000184937,ENSG00000197157",Original,BridgeBio,FGFR2 kinase inhibitor,Oncology,FGFR2-mutated bile duct cancer,bile duct cancer,MONDO_0003059,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3889654,2018,Vitrakvi,Larotrectinib,LAROTRECTINIB,"ENSG00000148053,ENSG00000198400,ENSG00000140538","ENSG00000081237,ENSG00000096384,ENSG00000105976,ENSG00000124181,ENSG00000127329,ENSG00000135333,ENSG00000140538,ENSG00000145675,ENSG00000146648,ENSG00000162733,ENSG00000198400,ENSG00000206503,ENSG00000149177,ENSG00000006125,ENSG00000127022,ENSG00000134259,ENSG00000160691,ENSG00000206052",Original,Loxo Oncology/Bayer,"TRKA, TRKB and TRKC inhibitor",Oncology,NTRK-positive solid cancers,salivary gland cancer; soft tissue sarcoma; thyroid cancer,"MONDO_0004669,EFO_1001968,MONDO_0002108",NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297841,2021,Tivdak,Tisotumab vedotin,Tisotumabvedotin,"ENSG00000117525,ENSG00000167552,ENSG00000258947,ENSG00000137267,ENSG00000188229,ENSG00000176014,ENSG00000261456,ENSG00000123416,ENSG00000198033,ENSG00000196230,ENSG00000167553,ENSG00000152086,ENSG00000104833,ENSG00000137285,ENSG00000101162,ENSG00000127824","ENSG00000065361,ENSG00000080824,ENSG00000083799,ENSG00000091831,ENSG00000126934,ENSG00000130779,ENSG00000133124,ENSG00000136997,ENSG00000146648,ENSG00000177606,ENSG00000179218,ENSG00000204843",Interactor,Seagen/Genmab,Tissue-factor-directed ADC,Oncology,Cervical cancer,cervical cancer,MONDO_0002974,NA,Original,Serious,"P,A",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL207538,2019,Zulresso,Brexanolone,BREXANOLONE,"ENSG00000094755,ENSG00000109158,ENSG00000186297,ENSG00000022355,ENSG00000145864,ENSG00000166206,ENSG00000182256,ENSG00000011677,ENSG00000268089,ENSG00000102287,ENSG00000113327,ENSG00000163285,ENSG00000151834,ENSG00000145863,ENSG00000163288,ENSG00000187730",NA,Original,Sage Therapeutics,GABAA-receptor-positive modulator,Other indication,Postpartum depression,postpartum depression,EFO_0007453,MONDO_0002050,Related,Not concordant,"P,B",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL4535757,2021,Lumakras,Sotorasib,Sotorasib,ENSG00000133703,"ENSG00000078061,ENSG00000133703,ENSG00000157764,ENSG00000067560,ENSG00000132155,ENSG00000142192,ENSG00000143398",Original,Amgen,KRAS-G12C inhibitor,Oncology,KRASG12C-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL441738,2019,Scenesse,Afamelanotide,AFAMELANOTIDE,ENSG00000258839,NA,Original,Clinuvel,Melanocortin 1 receptor agonist,Other indication,Erythropoietic protoporphyria,erythropoietic protoporphyria,MONDO_0001676,EFO_1000752,Related,Serious,"P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL2103837,2019,Vyndaqel,Tafamidis,TAFAMIDIS,ENSG00000118271,"ENSG00000118271,ENSG00000119614,ENSG00000128272,ENSG00000132016,ENSG00000138207,ENSG00000139372,ENSG00000142192,ENSG00000166595,ENSG00000198959",Original,Pfizer/Foldrx,Transthyretin stabilizer,Other indication,Heart disease caused by ATTR-CM,cardiomyopathy,EFO_0000318,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2107857,2014,Myalept,Metreleptin,METRELEPTIN,ENSG00000116678,"ENSG00000116678,ENSG00000174697,ENSG00000179295",Original,Amylin,Leptin analogue,Other indication,Leptin deficiency in patients with congenital or acquired generalized lipodystrophy,congenital generalized lipodystrophy,EFO_1000681,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108429,2015,Nucala,Mepolizumab,MEPOLIZUMAB,ENSG00000113525,NA,Original,GlaxoSmithKline,IL-5 antagonist,Other indication,Serious asthma,Status Asthmaticus,EFO_0008590,"MONDO_0004979,MONDO_0004979",Related,Serious,"S,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL396778,2017,Xadago,Safinamide,SAFINAMIDE,ENSG00000069535,"ENSG00000102466,ENSG00000163050",Interactor,US WorldMeds,MAO-B inhibitor,Other indication,Parkinson disease,Parkinson disease,MONDO_0005180,NA,Original,Serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2108278,2016,Exondys 51,Eteplirsen,ETEPLIRSEN,ENSG00000198947,"ENSG00000101400,NA",Original,Sarepta Therapeutics,ASO designed to target dystrophin pre-mRNA,Other indication,Duchenne muscular dystrophy,Duchenne muscular dystrophy,MONDO_0010679,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2403108,2014,Zykadia,Ceritinib,CERITINIB,"ENSG00000171094,ENSG00000143924,ENSG00000181163","ENSG00000165731,ENSG00000171094,ENSG00000091831,ENSG00000096384,ENSG00000104408,ENSG00000107882,ENSG00000127329,ENSG00000135679,ENSG00000141510,ENSG00000147889,ENSG00000164362,ENSG00000181163,ENSG00000198900,ENSG00000071894,ENSG00000115163,ENSG00000254093,ENSG00000001626,ENSG00000087586,ENSG00000116030,ENSG00000116478,ENSG00000137203,ENSG00000141456,ENSG00000149177,ENSG00000178999",Original,Novartis,"Kinase inhibitor against ALK, IGF1R, insulin receptor and ROS1",Oncology,ALK-positive metastatic NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL1509,CHEMBL1230314",2021,Nextstellis,"Drospirenone, estetrol","Drospirenone,estetrol","ENSG00000151623,ENSG00000082175,ENSG00000091831,ENSG00000140009","ENSG00000091831,ENSG00000091831,ENSG00000104447,ENSG00000132153,ENSG00000135250,ENSG00000135486,ENSG00000138078,ENSG00000143575,ENSG00000155561,ENSG00000158406,ENSG00000162244,ENSG00000167216,ENSG00000171456,ENSG00000171490,ENSG00000197728",Original,Mayne Pharma,Spironolactone and oestrogen analogues,Other indication,To prevent pregnancy,reproductive behaviour measurement,EFO_0007862,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707382,2017,Mepsevii,Vestronidase alfa,VESTRONIDASEALFA,ENSG00000169919,ENSG00000169919,Original,Ultragenyx,Recombinant human lysosomal ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-glucuronidase,Other indication,Mucopolysaccharidosis VII,mucopolysaccharidosis type 7,MONDO_0009662,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1742996,2017,Siliq,Brodalumab,BRODALUMAB,ENSG00000177663,NA,Original,Valeant Pharmaceuticals,IL-17RA antagonist,Other indication,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,EFO_0000676,Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3707267,2016,Axumin,Fluciclovine F-18,FLUCICLOVINEF-18,"ENSG00000155465,ENSG00000105281,ENSG00000165349",NA,Original,Blue Earth,Radioactive diagnostic,Other indication,Suspected prostate cancer recurrence,prostate cancer,MONDO_0008315,NA,Original,Serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL278623,2017,Macrilen,Macimorelin,MACIMORELIN,ENSG00000121853,"ENSG00000121853,ENSG00000116678",Original,Aeterna Zentaris,Growth hormone secretagogue receptor agonist,Other indication,Diagnosis of adult growth hormone deficiency,short stature due to GHSR deficiency,MONDO_0014403,NA,Original,Not serious,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1770248,2017,Steglatro,Ertugliflozin,ERTUGLIFLOZIN,ENSG00000140675,NA,Original,Merck & Co./Pfizer,SGLT2 inhibitor,Other indication,Type 2 diabetes mellitus,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Related,Not concordant,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL189963,2015,Ibrance,Palbociclib,PALBOCICLIB,"ENSG00000135446,ENSG00000110092,ENSG00000105810","ENSG00000110092,ENSG00000179750",Original,Pfizer,CDK4 and CDK6 inhibitor,Oncology,"ER-positive, HER2-negative advanced breast cancer",HER2 negative breast carcinoma,EFO_0009780,EFO_0000305,Original,Serious,"P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4559134,2020,Retevmo,Selpercatinib,SELPERCATINIB,"ENSG00000108091,ENSG00000165731,ENSG00000170759","ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000105568,ENSG00000108091,ENSG00000109670,ENSG00000110395,ENSG00000124181,ENSG00000160867,ENSG00000164305,ENSG00000168610,ENSG00000170759,ENSG00000113575,ENSG00000101266,ENSG00000104695,ENSG00000137076,ENSG00000168002,ENSG00000170027,ENSG00000188191",Original,Eli Lilly/Loxo Oncology,RET kinase inhibitor,Oncology,RET fusion-positive NSCLC and thyroid cancer,non-small cell lung carcinoma; thyroid cancer,"EFO_0003060,MONDO_0002108",NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2364653,2021,Saphnelo,Anifrolumab,Anifrolumab,ENSG00000142166,"ENSG00000105397,ENSG00000115415",Interactor,AstraZeneca,IFNAR-targeted mAb,Other indication,SLE,systemic lupus erythematosus,MONDO_0007915,NA,Original,Serious,"S,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3301572,2016,Spinraza,Nusinersen,NUSINERSEN,ENSG00000205571,"ENSG00000107290,ENSG00000172062,ENSG00000205571,ENSG00000079805,ENSG00000169057,ENSG00000182004,ENSG00000187191,ENSG00000197386,ENSG00000204410",Original,Biogen/Ionis Pharmaceuticals,ASO designed to target SMN2 pre-mRNA,Other indication,Spinal muscular atrophy,spinal muscular atrophy,EFO_0008525,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1738797,2015,Alecensa,Alectinib,ALECTINIB,"ENSG00000171094,ENSG00000143924,ENSG00000165731","ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000096384,ENSG00000107882,ENSG00000110395,ENSG00000124181,ENSG00000127329,ENSG00000160867,ENSG00000164305,ENSG00000168610,ENSG00000137076,ENSG00000149177",Original,Roche,ALK inhibitor,Oncology,NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1614701,2020,Koselugo,Selumetinib,SELUMETINIB,"ENSG00000169032,ENSG00000126934",NA,Original,AstraZeneca,MEK1/2 kinase inhibitor,Other indication,Neurofibromatosis type 1,neurofibromatosis type 1,MONDO_0018975,EFO_0008514,Related,Serious,"P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL4594320,2021,Nexviazyme,Avalglucosidase alfa,Avalglucosidasealfa,ENSG00000171298,NA,Original,Sanofi,Recombinant alpha-glucosidase,Other indication,Pompe disease,glycogen storage disease II,MONDO_0009290,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545110,2017,Kisqali,Ribociclib,RIBOCICLIB,"ENSG00000105810,ENSG00000135446","ENSG00000110092,ENSG00000179750",Interactor,Novartis,CDK4/6 inhibitor,Oncology,"HR-positive, HER2-negative breast cancer",HER2 negative breast carcinoma,EFO_0009780,EFO_0000305,Related,Serious,"P,B",TRUE,TRUE,TRUE,FALSE,FALSE
CHEMBL2111101,2016,Nuplazid,Pimavanserin,PIMAVANSERIN,ENSG00000102468,"ENSG00000102468,ENSG00000118432,ENSG00000147246,ENSG00000164082",Original,Acadia Pharmaceuticals,Atypical antipsychotic,Other indication,Hallucinations and delusions associated with Parkinson disease psychosis,Parkinson disease; psychosis,"MONDO_0005180,EFO_0005407",NA,Original,Serious,"P,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2070241,2019,Vyleesi,Bremelanotide,BREMELANOTIDE,ENSG00000166603,NA,Original,Amag,Melanocortin receptor agonist,Other indication,Hypoactive sexual desire disorder,sexual dysfunction,EFO_0004714,"EFO_0008343,EFO_0008343",Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL1173055,2016,Rubraca,Rucaparib,RUCAPARIB,"ENSG00000041880,ENSG00000129484,ENSG00000143799","ENSG00000141510,ENSG00000082805,ENSG00000091831,ENSG00000100030,ENSG00000148737,ENSG00000154767,ENSG00000156052,ENSG00000157554,ENSG00000164305,ENSG00000165392,ENSG00000168036,ENSG00000198900,ENSG00000245848,ENSG00000286522,ENSG00000004700,ENSG00000101412,ENSG00000148702,ENSG00000073050,ENSG00000092847,ENSG00000118518,ENSG00000131747,ENSG00000143799,ENSG00000147874,ENSG00000150991,ENSG00000166884,ENSG00000189403,ENSG00000196419,ENSG00000253729",Original,Clovis Oncology,PARP inhibitor,Oncology,BRCA-positive ovarian cancer,ovarian cancer,MONDO_0008170,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2103830,2018,Tavalisse,Fostamatinib,FOSTAMATINIB,ENSG00000165025,"ENSG00000012124,ENSG00000142192,ENSG00000162711",Interactor,Rigel Pharmaceuticals,SYK inhibitor,Other indication,Immune thrombocytopenic purpura,autoimmune thrombocytopenic purpura,EFO_0007160,NA,Original,Serious,"S,O",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3545367,2019,Dayvigo,Lemborexant,LEMBOREXANT,"ENSG00000121764,ENSG00000137252",NA,Original,Eisai,Orexin receptor antagonist,Other indication,Insomnia,insomnia,EFO_0004698,"EFO_0008568,EFO_0005271",Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL429910,2014,Farxiga,Dapagliflozin,DAPAGLIFLOZIN,ENSG00000140675,NA,Original,AstraZeneca,SGLT2 inhibitor,Other indication,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Related,Not concordant,"S,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3936761,2019,Brukinsa,Zanubrutinib,ZANUBRUTINIB,ENSG00000010671,"ENSG00000010671,ENSG00000117560",Original,BeiGene,BTK inhibitor,Oncology,Mantle cell lymphoma,mantle cell lymphoma,EFO_1001469,NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707326,2018,Crysvita,Burosumab,BUROSUMAB,ENSG00000118972,NA,Original,Ultragenyx Pharmaceutical/Kyowa Hakko Kirin,FGF23 antibody,Other indication,X-linked hypophosphataemia,Hypophosphatemia,HP_0002148,NA,Original,Not serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3545253,2020,Flortaucipir F-18,Flortaucipir F-18,FLORTAUCIPIRF-18,ENSG00000186868,"ENSG00000130203,ENSG00000142192,ENSG00000186868,ENSG00000136717",Original,Eli Lilly,Radioactive diagnostic,Other indication,"Imaging, tau in Alzheimer disease",Alzheimer disease,MONDO_0004975,NA,Original,Serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3099695,2020,Isturisa,Osilodrostat,OSILODROSTAT,ENSG00000160882,NA,Original,Recordati Rare Diseases,Cortisol synthesis inhibitor,Other indication,Cushing disease,Cushing syndrome,EFO_0003099,NA,Original,Not concordant,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1743041,2018,Poteligeo,Mogamulizumab,MOGAMULIZUMAB,ENSG00000183813,NA,Original,Kyowa Hakko Kirin,CCR4 antibody,Oncology,mycosis fungoides or Sezary syndrome,mycosis fungoides,EFO_1001051,MONDO_0015758,Related,Serious,"P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3989958,2018,Tibsovo,Ivosidenib,IVOSIDENIB,ENSG00000138413,"ENSG00000138413,ENSG00000072062,ENSG00000163513,ENSG00000179218",Original,Agios Pharmaceuticals,IDH1 inhibitor,Oncology,"IDH1-mutated AML, Locally Advanced or Metastatic Cholangiocarcinoma (*)",acute myeloid leukemia; cholangiocarcinoma,"EFO_0000222,EFO_0005221",NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2105395,2013,Osphena,Ospemifene,OSPEMIFENE,"ENSG00000140009,ENSG00000091831",NA,Original,Shionogi,Oestrogen receptor modulator,Other indication,Moderate to Serious dyspareunia due to menopause,Dyspareunia,HP_0030016,NA,Original,Not serious,S,FALSE,FALSE,FALSE,FALSE,FALSE
CHEMBL571546,2020,Klisyri,Tirbanibulin,TIRBANIBULIN,ENSG00000197122,ENSG00000174775,Interactor,Athenex,Microtubule inhibitor,Other indication,Actinic keratosis,actinic keratosis,EFO_0002496,EFO_0003784,Related,Not serious,S,TRUE,TRUE,TRUE,FALSE,FALSE
"CHEMBL235668,CHEMBL1129",2015,Lonsurf,"Tipiracil, trifluridine","TIPIRACIL,TRIFLURIDINE","ENSG00000025708,ENSG00000176890",NA,Original,Taiho,Thymidine phosphorylase inhibitor plus a nucleoside metabolic inhibitor,Oncology,Colorectal cancer,colorectal cancer,EFO_0005842,NA,Original,Serious,"S,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3833384,2022,Rolvedon,Eflapegrastim,Eflapegrastim,ENSG00000119535,NA,Original,Spectrum,Leukocyte growth factor,Other indication,"Incidence of infection in non-myeloid malignancies, with myelosuppressive drugs",infection,EFO_0000544,Orphanet_169142,Related,Serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL1873475,2013,Imbruvica,Ibrutinib,IBRUTINIB,ENSG00000010671,"ENSG00000010671,ENSG00000117560",Original,Pharmacyclics,Bruton's tyrosine kinase inhibitor,Oncology,Mantle cell lymphoma,Mantle cell lymphoma,EFO_1001469,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3833319,2018,Yupelri,Revefenacin,REVEFENACIN,ENSG00000133019,NA,Original,Theravance Biopharma/Mylan,Long-acting muscarinic receptor antagonist,Other indication,COPD,chronic obstructive pulmonary disease,EFO_0000341,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2338675,2021,Nulibry,Fosdenopterin,Fosdenopterin,ENSG00000164172,ENSG00000164172,Original,BridgeBio,cPMP,Other indication,MoCD type A,sulfite oxidase deficiency due to molybdenum cofactor deficiency,MONDO_0020480,NA,Original,Serious,"P,O,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL514800,2014,Otezla,Apremilast,APREMILAST,"ENSG00000184588,ENSG00000065989,ENSG00000105650,ENSG00000113448",NA,Original,Celgene,Phosphodiesterase 4 inhibitor,Other indication,Psoriatic arthritis and plaque psoriasis,psoriatic arthritis; psoriasis vulgaris,"EFO_0003778,EFO_1001494",EFO_0000676,Related,Serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3137320,2018,Talzenna,Talazoparib,TALAZOPARIB,"ENSG00000143799,ENSG00000129484",ENSG00000091831,Interactor,Pfizer,PARP inhibitor,Oncology,BRCA-mutated HER2-negative breast cancer,HER2 negative breast carcinoma,EFO_0009780,EFO_0000305,Related,Serious,P,TRUE,TRUE,TRUE,FALSE,FALSE
CHEMBL2108311,2015,Strensiq,Asfotase alfa,ASFOTASEALFA,ENSG00000162551,NA,Original,Alexion,Alkaline phosphatase,Other indication,Hypophosphatasia,hypophosphatasia,MONDO_0018570,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707227,2016,Tecentriq,Atezolizumab,ATEZOLIZUMAB,ENSG00000120217,ENSG00000197646,Original,Genentech,PDL1 inhibitor,Oncology,Urothelial carcinoma,urothelial carcinoma,EFO_0008528,NA,Original,Serious,"P,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3039540,2021,Aduhelm,Aducanumab,Aducanumab,ENSG00000142192,"ENSG00000080815,ENSG00000130203,ENSG00000137642,ENSG00000137845,ENSG00000142192,ENSG00000143801,ENSG00000186868,ENSG00000070808,ENSG00000132535,ENSG00000007047,ENSG00000073060,ENSG00000120885,ENSG00000120899,ENSG00000121653,ENSG00000129219,ENSG00000131042,ENSG00000138613,ENSG00000163879,ENSG00000165916,ENSG00000168077",Original,Biogen/Eisai,Amyloid-beta-targeted mAb,Other indication,Alzheimers disease,Alzheimers disease,MONDO_0004975,NA,Original,Serious,"P,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3137309,2016,Venclexta,Venetoclax,VENETOCLAX,ENSG00000171791,"ENSG00000029363,ENSG00000087088,ENSG00000100030,ENSG00000141510,ENSG00000171791,ENSG00000198625,ENSG00000030110,ENSG00000141682,ENSG00000153094,ENSG00000123358",Original,AbbVie,BCL-2 inhibitor,Oncology,Chronic lymphocytic leukaemia,chronic lymphocytic leukemia,EFO_0000095,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3301581,2017,Tymlos,Abaloparatide,ABALOPARATIDE,ENSG00000160801,"ENSG00000087494,ENSG00000168036",Interactor,Radius Health,Parathyroid hormone-related protein,Other indication,Osteoporosis,osteoporosis,EFO_0003882,NA,Original,Not serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL1083659,2014,Belsomra,Suvorexant,SUVOREXANT,"ENSG00000137252,ENSG00000121764",NA,Original,Merck & Co.,Orexin-receptor antagonist,Other indication,Insomnia,insomnia,EFO_0004698,"EFO_0008568,EFO_0005271",Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3039502,2018,Copiktra,Duvelisib,DUVELISIB,"ENSG00000105851,ENSG00000171608","ENSG00000145675,ENSG00000166501,ENSG00000174775",Interactor,Verastem,PI3K inhibitor,Oncology,"CLL, FL and SLL",chronic lymphocytic leukemia; follicular lymphoma,"EFO_0000095,MONDO_0018906",EFO_0000183,Related,Serious,"P,O,A,F",TRUE,TRUE,TRUE,FALSE,FALSE
CHEMBL3187723,2018,Mektovi,Binimetinib,BINIMETINIB,"ENSG00000169032,ENSG00000126934","ENSG00000132155,ENSG00000157764,ENSG00000078061,ENSG00000100030,ENSG00000108953,ENSG00000102882,ENSG00000109971,ENSG00000137693,ENSG00000141068,ENSG00000142192,ENSG00000166913,ENSG00000172530",Original,Array BioPharma,MEK inhibitor,Oncology,BRAF-mutated melanoma,melanoma,EFO_0000756,NA,Original,Serious,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297852,2018,Oxervate,Cenegermin,CENEGERMIN,"ENSG00000140538,ENSG00000148053,ENSG00000198400","ENSG00000142192,ENSG00000146648",Interactor,Domp‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®¬¨¬©,Recombinant NGF,Other indication,Neurotrophic keratitis,keratitis,EFO_0009449,NA,Original,Not serious,"P,O,B,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4297610,2022,Rezlidhia,Olutasidenib,Olutasidenib,ENSG00000138413,"ENSG00000138413,ENSG00000072062,ENSG00000163513,ENSG00000179218",Original,Rigel/Forma,IDH1 inhibitor,Oncology,IDH1-mutated AML,acute myeloid leukemia,EFO_0000222,NA,Original,Serious,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL1187833,CHEMBL1198857",2013,Anoro Ellipta,"Umeclidinium, vilanterol","UMECLIDINIUM,VILANTEROL","ENSG00000133019,ENSG00000169252","ENSG00000113369,ENSG00000163485,NA",Original,GSK,Anticholinergic and a LABA,Other indication,Chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO_0000341,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297770,2018,Tegsedi,Inotersen,INOTERSEN,ENSG00000118271,ENSG00000118271,Original,Ionis Pharmaceuticals,TTR-directed antisense oligonucleotide,Other indication,Hereditary TTR-mediated amyloidosis,hereditary ATTR amyloidosis,MONDO_0017132,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297778,2021,Zynlonta,Loncastuximab tesirine,Loncastuximabtesirine,ENSG00000177455,ENSG00000211899,Original,ADC Therapeutics,CD19-targeted ADC,Oncology,B-cell lymphoma,B-cell non-Hodgkins lymphoma,EFO_1001938,NA,Original,Serious,"P,O,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4066936,2021,Verquvo,Vericiguat,Vericiguat,"ENSG00000123201,ENSG00000061918,ENSG00000152402,ENSG00000164116","ENSG00000061918,ENSG00000164116",Original,Merck & Co./Bayer,sGC stimulator,Other indication,Chronic heart failure,coronary artery disease,EFO_0001645,NA,Original,Serious,"P,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL376359,2013,Nesina,Alogliptin,ALOGLIPTIN,ENSG00000197635,"ENSG00000197635,ENSG00000159224,ENSG00000169248",Original,Takeda,DPP4 inhibitor,Other indication,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2042122,2013,Vizamyl,Flutemetamol F-18,FLUTEMETAMOLF-18,ENSG00000142192,"ENSG00000080815,ENSG00000130203,ENSG00000137642,ENSG00000137845,ENSG00000142192,ENSG00000143801,ENSG00000186868,ENSG00000070808,ENSG00000132535,ENSG00000007047,ENSG00000073060,ENSG00000120885,ENSG00000120899,ENSG00000121653,ENSG00000128482,ENSG00000129219,ENSG00000131042,ENSG00000138613,ENSG00000139318,ENSG00000163879,ENSG00000165916,ENSG00000168077",Original,GE Healthcare,Radioactive diagnostic agent,Other indication,PET imaging of the brain to estimate beta-amyloid neuritic plaque density in patients who are being evaluated for Alzheimer's disease,neuritic plaque measurement; Alzheimer disease,"EFO_0006798,MONDO_0004975",NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2364648,2017,Tremfya,Guselkumab,GUSELKUMAB,"ENSG00000113302,ENSG00000110944","ENSG00000110944,ENSG00000113302,ENSG00000162594",Original,Janssen/Johnson & Johnson,IL-23 blocker,Other indication,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,EFO_0000676,Original,Not serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4582651,2020,Gavreto,Pralsetinib,PRALSETINIB,"ENSG00000170759,ENSG00000165731,ENSG00000108091","ENSG00000146648,ENSG00000165731,ENSG00000171094,ENSG00000105568,ENSG00000108091,ENSG00000109670,ENSG00000110395,ENSG00000124181,ENSG00000160867,ENSG00000164305,ENSG00000168610,ENSG00000170759,ENSG00000113575,ENSG00000104695,ENSG00000137076,ENSG00000168002,ENSG00000170027,ENSG00000188191",Original,Blueprint Medicines/Roche,RET kinase inhibitor,Oncology,RET fusion-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2219536,2013,Kynamro,Mipomersen,MIPOMERSEN,ENSG00000084674,"ENSG00000130164,ENSG00000138823",Original,Genzyme,Oligonucleotide inhibitor of apolipoprotein B100 synthesis,Other indication,Homozygous familial hypercholesterolaemia,homozygous familial hypercholesterolemia,MONDO_0018328,EFO_0004611,Original,Serious,"S,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297723,2018,Libtayo,Cemiplimab,CEMIPLIMAB,ENSG00000188389,"ENSG00000120217,ENSG00000179295,ENSG00000197646,ENSG00000006125,ENSG00000121594",Interactor,Regeneron/Sanofi,PD1 antibody,Oncology,"CSCC, BCC(*), NSCLC(*)",cutaneous squamous cell carcinoma; basal cell carcinoma; non-small cell lung carcinoma,"EFO_1001927,EFO_0004193,EFO_0003060",NA,Original,Serious,"P,B",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4297528,2020,Evrysdi,Risdiplam,RISDIPLAM,ENSG00000205571,"ENSG00000107290,ENSG00000172062,ENSG00000205571,ENSG00000079805,ENSG00000169057,ENSG00000182004,ENSG00000187191,ENSG00000197386,ENSG00000204410",Original,Roche/Genentech,SMN2 splicing modifier,Other indication,Spinal muscular atrophy,spinal muscular atrophy,EFO_0008525,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2107834,2013,Adempas,Riociguat,RIOCIGUAT,"ENSG00000123201,ENSG00000164116,ENSG00000061918,ENSG00000152402",ENSG00000164116,Original,Bayer,Soluble guanylyl cyclase stimulator,Other indication,Persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension,pulmonary arterial hypertension,EFO_0001361,EFO_0000537,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL315985,2013,Aptiom,Eslicarbazepine,ESLICARBAZEPINE,"ENSG00000168356,ENSG00000169432,ENSG00000144285,ENSG00000007314,ENSG00000136546,ENSG00000185313,ENSG00000136531,ENSG00000183873,ENSG00000196876,ENSG00000153253","ENSG00000102466,ENSG00000105711,ENSG00000114279,NA",Original,Sunovion,"MOA unknown, but thought to involve voltage-gated sodium channels",Other indication,Partial-onset seizures,Seizure,HP_0001250,NA,Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3833373,2017,Bavencio,Avelumab,AVELUMAB,ENSG00000120217,ENSG00000197646,Original,Merck KGaA/Pfizer,PDL1-blocking antibody,Oncology,Merkel cell carcinoma,Merkel cell skin cancer,EFO_1001471,NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108027,2014,Trulicity,Dulaglutide,DULAGLUTIDE,ENSG00000112164,NA,Original,Eli Lilly,GLP1-receptor agonist,Other indication,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2109540,2015,Praluent,Alirocumab,ALIROCUMAB,ENSG00000169174,ENSG00000130164,Original,Sanofi,PCSK9 inhibitor,Other indication,LDL lowering,low density lipoprotein cholesterol measurement,EFO_0004611,NA,Original,Not serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2103822,2014,Hetlioz,Tasimelteon,TASIMELTEON,"ENSG00000134640,ENSG00000168412",NA,Original,Vanda,Melatonin-receptor agonist,Other indication,Non-24-hour sleep-wake disorder,sleep-wake disorder,MONDO_0003406,EFO_0008328,Related,Not serious,"P,O",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL1287853,2019,Inrebic,Fedratinib,FEDRATINIB,"ENSG00000096968,ENSG00000122025","ENSG00000096968,ENSG00000097007,ENSG00000117400,ENSG00000122025,ENSG00000179295",Original,Celgene/BMS,JAK2 and FLT3 inhibitor,Other indication,Myelofibrosis,myelofibrosis,MONDO_0044903,NA,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1800159,2020,Orgovyx,Relugolix,RELUGOLIX,ENSG00000109163,NA,Original,Myovant Sciences,GnRH receptor antagonist,Oncology,Prostate cancer,prostate cancer,MONDO_0008315,NA,Original,Serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3306803,2019,Caplyta,Lumateperone,LUMATEPERONE,"ENSG00000102468,ENSG00000108576,ENSG00000149295","ENSG00000078369,ENSG00000102468,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147246,ENSG00000147955,ENSG00000162946,ENSG00000164082,ENSG00000149295",Original,Intra-Cellular Therapies,Atypical antipsychotic,Other indication,Schizophrenia,schizophrenia,MONDO_0005090,NA,Original,Not concordant,"S,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2364638,2019,Ubrelvy,Ubrogepant,UBROGEPANT,ENSG00000064989,ENSG00000110680,Interactor,Allergan,CGRP receptor antagonist,Other indication,Migraine with or without aura,migraine disorder,MONDO_0005277,NA,Original,Not serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4297750,2022,Vabysmo,Faricimab,Faricimab,"ENSG00000112715,ENSG00000091879","ENSG00000099250,ENSG00000112715",Original,Roche/Genentech,VEGF _ ANG2 bispecific antibody,Other indication,nAMD and DME,age-related macular degeneration,EFO_0001365,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108724,2017,Ozempic,Semaglutide,SEMAGLUTIDE,ENSG00000112164,NA,Original,Novo Nordisk,GLP1 receptor agonist,Other indication,Type 2 diabetes mellitus,type 2 diabetes mellitus,MONDO_0005148,"HP_0003076,Orphanet_79161",Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3991065,2021,Qulipta,Atogepant,Atogepant,ENSG00000064989,ENSG00000110680,Interactor,AbbVie,CGRP receptor antagonist,Other indication,Episodic migraine,migraine disorder,MONDO_0005277,NA,Original,Not serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2107333,2013,Tecfidera,Dimethyl fumarate,DIMETHYLFUMARATE,ENSG00000079999,NA,Original,Biogen Idec,MOA unknown; activates NRF2 pathway,Other indication,Relapsing forms of multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,MONDO_0005301,Related,Serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL2108658,2022,Imjudo,Tremelimumab,Tremelimumab,ENSG00000163599,ENSG00000145675,Interactor,AstraZeneca,CTLA4-targeted mAb,Oncology,Hepatocellular carcinoma,hepatocellular carcinoma,EFO_0000182,MONDO_0018531,Original,Serious,"S,O",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL1743049,2016,Lartruvo,Olaratumab,OLARATUMAB,ENSG00000134853,"ENSG00000100311,ENSG00000113721,ENSG00000124181,ENSG00000146648",Original,Eli Lilly,PDGFRalpha-blocking antibody,Oncology,Soft tissue sarcoma,soft tissue sarcoma,EFO_1001968,NA,Original,Serious,"P,O,B,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3833329,2018,Aimovig,Erenumab,ERENUMAB,ENSG00000064989,ENSG00000110680,Interactor,Amgen/Novartis,CGRP receptor antibody,Other indication,Migraine,migraine disorder,MONDO_0005277,NA,Original,Not serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL608533,2017,Rydapt,Midostaurin,MIDOSTAURIN,"ENSG00000163932,ENSG00000115825,ENSG00000166501,ENSG00000171132,ENSG00000163558,ENSG00000184304,ENSG00000065675,ENSG00000126583,ENSG00000027075,ENSG00000067606,ENSG00000154229,ENSG00000128052,ENSG00000122025,ENSG00000157404,ENSG00000134853,ENSG00000113721",NA,Original,Novartis,FLT3 inhibitor,Oncology,FLT3-positive AML,"acute myeloid leukemia, FLT3 internal tandem duplication",MONDO_0100415,EFO_0000222,Related,Serious,"P,O,B,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3989924,2018,Lutathera,Lutetium Lu 177 dotatate,LUTETIUMLU177DOTATATE,"ENSG00000139874,ENSG00000162009,ENSG00000278195,ENSG00000132671,ENSG00000180616",ENSG00000145675,Interactor,Advanced Accelerator Applications/Novartis,Somatostatin receptor-targeted radiopharmaceutical,Oncology,GEP-NETs,digestive system neuroendocrine neoplasm,MONDO_0024503,NA,Original,Serious,"P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2107869,2015,Tresiba,Insulin degludec,INSULINDEGLUDEC,ENSG00000171105,"ENSG00000145675,ENSG00000254647,ENSG00000169047,ENSG00000171105,ENSG00000197594,ENSG00000075624,ENSG00000081237,ENSG00000106070,ENSG00000135439,ENSG00000178188,ENSG00000179295,ENSG00000185950,ENSG00000196396,ENSG00000124181,ENSG00000140443,ENSG00000149177,ENSG00000153233",Original,Novo Nordisk,Long-acting insulin,Other indication,Diabetes,diabetes mellitus,EFO_0000400,NA,Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2043437,2018,Daurismo,Glasdegib,GLASDEGIB,ENSG00000128602,ENSG00000185920,Original,Pfizer,Hedgehog pathway inhibitor,Oncology,AML,acute myeloid leukemia,EFO_0000222,NA,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2107874,2019,Evenity,Romosozumab,ROMOSOZUMAB,ENSG00000167941,"ENSG00000162337,ENSG00000070018",Original,Amgen,Sclerostin inhibitor,Other indication,Osteoporosis,osteoporosis,EFO_0003882,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4594406,2022,Pluvicto,Lutetium Lu-177 vipivotide tetraxetan,LutetiumLu-177vipivotidetetraxetan,ENSG00000142515,ENSG00000169083,Original,Novartis,PSMA-binding radioligand therapeutic agent,Oncology,PSMA-positive prostate cancer,prostate carcinoma,EFO_0001663,NA,Original,Serious,"P,B",TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL3707377,CHEMBL691",2018,Annovera,"Segesterone acetate, ethinyl estradiol","SEGESTERONEACETATE,ETHINYLESTRADIOL","ENSG00000082175,ENSG00000091831","ENSG00000091831,ENSG00000091831",Original,TherapeuticsMD,Progestin and estrogen combined hormonal contraceptive,Other indication,Female contraception,contraception,EFO_0009520,NA,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297340,2016,Netspot,Gallium Ga-68 dotatate,GALLIUMGA-68DOTATATE,ENSG00000180616,ENSG00000145675,Interactor,Advanced Accelerator Applications,Radioactive diagnostic,Other indication,Neuroendocrine tumours,neuroendocrine neoplasm,EFO_1001901,NA,Original,Serious,"P,O",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL2103883,2018,Doptelet,Avatrombopag,AVATROMBOPAG,ENSG00000117400,"NA,ENSG00000096968",Original,Dova Pharmaceuticals,Thrombopoietin receptor agonist,Other indication,Thrombocytopenia,thrombocytopenia,HP_0001873,NA,Original,Not concordant,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2108681,2018,Ilumya,Tildrakizumab,TILDRAKIZUMAB,"ENSG00000110944,ENSG00000113302","ENSG00000110944,ENSG00000113302,ENSG00000162594",Original,Sun Pharma,IL-23 antibody,Other indication,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,EFO_0000676,Original,Not serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4204794,2020,Ayvakit,Avapritinib,AVAPRITINIB,"ENSG00000157404,ENSG00000134853","NA,ENSG00000111252,ENSG00000113721,ENSG00000146648,ENSG00000049130",Original,Blueprint Medicines,"PDGFRA, PDGFRA mutants and KIT kinase inhibitor",Oncology,GIST with PDGFRA exon 18 mutations,gastrointestinal stromal tumor,MONDO_0011719,NA,Original,Serious,"P,O,B,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL607400,2016,Briviact,Brivaracetam,BRIVARACETAM,"ENSG00000159164,ENSG00000144285",NA,Original,UCB,"Anticonvulsant with unknown MOA, binds to SV2A",Other indication,Partial-onset seizures,Focal-onset seizure,HP_0007359,HP_0001250,Original,Not concordant,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1743007,2015,Darzalex,Daratumumab,DARATUMUMAB,ENSG00000004468,NA,Original,Johnson & Johnson,CD38-directed mAb,Oncology,Multiple myeloma,multiple myeloma,EFO_0001378,MONDO_0004095,Related,Serious,"P,O,B,A,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL2218919,2021,Lupkynis,Voclosporin,Voclosporin,ENSG00000138814,NA,Original,Aurinia,Calcineurin inhibitor,Other indication,Lupus nephritis,lupus nephritis,EFO_0005761,MONDO_0007915,Related,Serious,"P,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3707348,2017,Calquence,Acalabrutinib,ACALABRUTINIB,ENSG00000010671,"ENSG00000010671,ENSG00000117560",Original,AstraZeneca/Acerta Pharma,BTK inhibitor,Oncology,Mantle cell lymphoma,Mantle cell lymphoma,EFO_1001469,NA,Original,Serious,"P,O,B,A",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3701238,2022,Lytgobi,Futibatinib,Futibatinib,"ENSG00000068078,ENSG00000077782,ENSG00000160867,ENSG00000066468",NA,Original,Taiho Oncology,FGFR kinase inhibitor,Oncology,FGFR2-aberrant intrahepatic cholangiocarcinoma,intrahepatic cholangiocarcinoma,EFO_1001961,EFO_0005221,Related,Serious,"P,O,B,A,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL502182,2018,Orilissa,Elagolix sodium,ELAGOLIXSODIUM,ENSG00000109163,NA,Original,AbbVie,GnRH receptor antagonist,Other indication,Pain associated with endometriosis,adenomyosis; pain,"MONDO_0010888,EFO_0003843",NA,Original,Not serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2103827,2014,Northera,Droxidopa,DROXIDOPA,"ENSG00000169252,ENSG00000170214,ENSG00000043591,ENSG00000120907,ENSG00000274286,ENSG00000184160,ENSG00000188778,ENSG00000150594,ENSG00000171873","ENSG00000171867,ENSG00000185359,ENSG00000197971",Interactor,Lundbeck,Synthetic amino-acid precursor of noradrenaline; MOA unknown,Other indication,Light-headedness in patients with neurogenic orthostatic hypotension,primary orthostatic hypotension,MONDO_0015914,NA,Original,Not serious,"P,O,A,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3833307,2020,Enspryng,Satralizumab,SATRALIZUMAB,"ENSG00000160712,ENSG00000134352",NA,Original,Roche/Genentech,IL-6R-directed mAb,Other indication,NMOSD,neuromyelitis optica,EFO_0004256,MONDO_0000568,Related,Serious,"S,O,B,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3039545,2019,Reblozyl,Luspatercept,LUSPATERCEPT,"ENSG00000105329,ENSG00000092969,ENSG00000119699","ENSG00000049323,ENSG00000076248,ENSG00000105329,ENSG00000105991,ENSG00000138615,ENSG00000151615,ENSG00000163430",Original,Celgene/BMS,Erythroid maturation agent,Other indication,Anaemia in beta-thalassaemia,beta thalassemia; anemia,"MONDO_0019402,MONDO_0002280",NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2105759,2018,Olumiant,Baricitinib,BARICITINIB,"ENSG00000096968,ENSG00000162434","ENSG00000096968,ENSG00000100368,ENSG00000134352,ENSG00000162434,ENSG00000065361,ENSG00000115415,ENSG00000168610",Original,Incyte/Eli Lilly,JAK inhibitor,Other indication,Rheumatoid arthritis,rheumatoid arthritis,EFO_0000685,NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2028663,2013,Tafinlar,Dabrafenib,DABRAFENIB,ENSG00000157764,NA,Original,GSK,"Kinase inhibitor with activity against BRAFV600E, BRAFV600K, BRAFV600D, wild-type BRAF and other kinases",Oncology,Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test,metastatic melanoma,EFO_0002617,EFO_0000756,Related,Serious,"S,O,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL4297517,2022,Camzyos,Mavacamten,Mavacamten,ENSG00000092054,ENSG00000134571,Original,Bristol Myers Squibb,Cardiac myosin inhibitor,Other indication,Classes of obstructive HCM (Hypertrophic Obstructive Cardiomyopathy),hypertrophic cardiomyopathy,EFO_0000538,NA,Original,Serious,"S,O,B",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1289601,2015,Lenvima,Lenvatinib,LENVATINIB,"ENSG00000037280,ENSG00000128052,ENSG00000102755","ENSG00000037280,ENSG00000096384,ENSG00000110395,ENSG00000111679,ENSG00000128052,ENSG00000145675,ENSG00000197122,ENSG00000112715,ENSG00000149177,ENSG00000158092,ENSG00000160691",Original,Eisai,VEGFR inhibitor,Oncology,Thyroid cancer,thyroid cancer,MONDO_0002108,NA,Original,Serious,"P,O",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL1743062,2014,Cyramza,Ramucirumab,RAMUCIRUMAB,ENSG00000128052,"ENSG00000037280,ENSG00000111679,ENSG00000128052,ENSG00000197122,ENSG00000067225,ENSG00000142798,ENSG00000160691,ENSG00000179776",Original,Eli Lilly,VEGFR2 antagonist,Oncology,Gastric cancer,gastric cancer,MONDO_0001056,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL484785,2016,Eucrisa,Crisaborole,CRISABOROLE,"ENSG00000184588,ENSG00000113448,ENSG00000065989,ENSG00000105650",NA,Original,Pfizer/Anacor Pharmaceuticals,PDE4 inhibitor,Other indication,Atopic dermatitis,atopic eczema,EFO_0000274,"HP_0000964,MONDO_0002406",Related,Not serious,S,TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL605846,2014,Striverdi Respimat,Olodaterol,OLODATEROL,ENSG00000169252,"ENSG00000113369,ENSG00000163485",Interactor,Boehringer Ingelheim,Long-acting beta2-adrenoceptor agonist,Other indication,COPD,chronic obstructive pulmonary disease,EFO_0000341,NA,Original,Serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL3218576,2017,Aliqopa,Copanlisib dihydrochloride,COPANLISIB,"ENSG00000171608,ENSG00000121879",NA,Original,Bayer,PI3Kalpha/‚Äö√¢√†‚àö‚â†¬¨¬®‚Äö√Ñ¬¢ inhibitor,Oncology,Follicular lymphoma,follicular lymphoma,MONDO_0018906,EFO_0000183,Related,Serious,"P,O,A,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL3707226,2016,Defitelio,Defibrotide sodium,DEFIBROTIDESODIUM,ENSG00000122194,NA,Original,Gentium,Profibrinolytic,Other indication,Hepatic veno-occlusive disease,hepatic veno-occlusive disease,MONDO_0019514,MONDO_0002405,Related,Serious,"P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL363392,2021,Livmarli,Maralixibat,Maralixibat,ENSG00000125255,NA,Original,Mirum,IBAT inhibitor,Other indication,Pruritus in Alagille syndrome,Alagille syndrome,MONDO_0007318,EFO_0005653,Related,Serious,"P,O,B",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL2109624,2019,Cablivi,Caplacizumab,CAPLACIZUMAB,ENSG00000110799,ENSG00000160323,Interactor,Sanofi/Ablynx,vWF-directed nanobody,Other indication,ATTP,thrombotic thrombocytopenic purpura,MONDO_0018896,NA,Original,Serious,"P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4298211,2021,Empaveli,Pegcetacoplan,Pegcetacoplan,ENSG00000125730,ENSG00000155659,Interactor,Apellis,Complement protein C3 inhibitor,Other indication,PNH,paroxysmal nocturnal hemoglobinuria,MONDO_0100244,NA,Original,Serious,"P,O,F",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL566315,2016,Ocaliva,Obeticholic acid,OBETICHOLICACID,ENSG00000012504,NA,Original,Intercept,FXR agonist,Other indication,Primary biliary cholangitis,primary biliary cirrhosis,EFO_1001486,EFO_0001422,Related,Serious,"P,O,A,F",TRUE,FALSE,TRUE,FALSE,FALSE
CHEMBL2108676,2014,Vimizim,Elosulfase alfa,ELOSULFASEALFA,ENSG00000141012,NA,Original,BioMarin,Hydrolytic lysosomal glycosaminoglycan-specific enzyme,Other indication,Mucopolysaccharidosis type IVA,mucopolysaccharidosis type 4A,MONDO_0009659,NA,Original,Serious,"P,O,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL4297819,2021,Besremi,Ropeginterferon alfa-2b,Ropeginterferonalfa-2b,"ENSG00000142166,ENSG00000159110","ENSG00000162434, ",Interactor,Pharmaessentia,PEGylated interferon alpha-2b,Oncology,Polycythaemia vera,polycythemia vera,EFO_0002429,NA,Original,Serious,"S,O",TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL431770,2019,Nourianz,Istradefylline,ISTRADEFYLLINE,ENSG00000128271,ENSG00000149295,Interactor,Kyowa Kirin,Adenosine receptor antagonist,Other indication,Parkinson disease episodes,Parkinson disease,MONDO_0005180,NA,Original,Serious,S,TRUE,TRUE,FALSE,FALSE,FALSE
CHEMBL4298062,2020,Viltepso,Viltolarsen,VILTOLARSEN,ENSG00000198947,"ENSG00000101400,NA",Original,Nippon Shinyaku,Dystrophin splicing modifier,Other indication,Duchenne muscular dystrophy,duchenne muscular dystrophy,MONDO_0010679,NA,Original,Serious,"P,O,A,F",TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL2028019,2015,Vraylar,Cariprazine,CARIPRAZINE,"ENSG00000151577,ENSG00000149295","ENSG00000078369,ENSG00000118432,ENSG00000128271,ENSG00000142319,ENSG00000147955,ENSG00000162946,ENSG00000149295,NA",Original,Forest,Atypical antipsychotic,Other indication,Schizophrenia and bipolar 1 disorder,Schizophrenia; bipolar disorder,"MONDO_0005090,MONDO_0004985",NA,Original,Serious,S,TRUE,FALSE,FALSE,FALSE,TRUE
CHEMBL3707229,2021,Tezspire,Tezepelumab,Tezepelumab,ENSG00000145777,NA,Original,Astrazeneca/Amgen,TSLP-targeted mAb,Other indication,Serious asthma,asthma,MONDO_0004979,EFO_0004842,Original,Serious,P,TRUE,FALSE,FALSE,FALSE,TRUE
"CHEMBL3990044,CHEMBL2108738",2022,Opdualag,"Relatlimab, nivolumab","Relatlimab,nivolumab","ENSG00000089692,ENSG00000188389","ENSG00000120217,ENSG00000179295,ENSG00000197646,ENSG00000006125",Interactor,Bristol Myers Squibb,LAG3-targeted mAb plus PD1-targeted mAb,Oncology,Melanoma,melanoma,EFO_0000756,NA,Related,Serious,"P,O,F",TRUE,FALSE,TRUE,FALSE,FALSE